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ABSTRACT 
 
 
LINA GAO: ROS-Induced DNA Damage in Rodents after Exposure to Superfund 
Hazardous Chemicals 
(Under the direction of James A. Swenberg) 
 
          The accumulation of oxidative DNA damage has been hypothesized as a key event 
in chemical carcinogenesis. In this study, oxidative DNA damage was evaluated in the 
livers of rats exposed to vinyl chloride (VC), 2,3,7,8-tetrachlorodibenzo-p-dioxin 
(TCDD), 3,3΄,4,4΄,5-pentachlorobiphenyl (PCB 126), 2,3,4,7,8-pentachlorodibenzofuran 
(PeCDF) and 2,2΄,4,4΄,5,5΄-Hexachlorobiphenyl (PCB153). Eight oxidative DNA adducts 
were measured, 8-hydroxyl-2′-deoxyguanosine (8-OHdG), 1, N6-etheno-2’-
deoxyadenosine (εdA), N2, 3-εG, 1, N2-etheno-2’-deoxyguanosine (1, N2-εdG), 3-(2′-
deoxy-β-d-erythro-pentofuranosyl) pyrimido[1,2-α]purin-10(3H) (M1dG), acrolein, 
crotonaldehyde and 4-HNE -derived dG adducts (assigned as AcrdG, CrdG, and 4-
HNEdG respectively). 
 
         εdA is one of the promutagenic DNA adducts formed by VC, which can also be 
formed by lipid peroxidation. In this study, both adult and weanling Sprague-Dawley rats 
were exposed to 1100 ppm (13C2)-VC for 1 week (6 h/day, 5 days/week). The results 
indicated that NA-εdA concentration did not show significant difference in the liver of 
adult and weanling rats after VC exposure. The distribution pattern of (13C2)-εdA in liver, 
lung and kidney indicated that liver was the dominant target organ for VC toxicity in both 
 iv 
 
adult and weanling rats. ROS-induced DNA adducts were detected in the liver of female 
intact, ovariectomized (OVX) and male Sprague-Dawley rats, including 8-OHdG, 1, N6-
εdA, AcrdG, and CrdG. These animals were exposed to TCDD for 30 weeks after 
diethylnitrosamine (DEN) initiation. Induction of these adducts was consistently found in 
liver DNA of TCDD-treated intact female rats and 17β-estradiol (E2) supplemented OVX 
female rats, but not detected in OVX rats without E2 supplement or male rats. These 
results further confirmed that the induction of these adducts occurs via a sex-specific and 
estrogen-dependent mechanism reported previously. Oxidative DNA damage was 
measured in liver DNA of female Sprague-Dawley rats following 53-week exposure of 
PHAHs, including PCB153, PCB126, TCDD, and the ternary mixture of TCDD, PCB126 
and PeCDF. Increases of 8-OHdG, N2, 3-εG and 1, N6-εdA were observed in PCB153 or 
PCB126 exposed animals. Significant increases of 1, N6-εdA were observed in all 
animals exposed to TCDD and the ternary mixture. Increases of 1, N2-εdG, CrdG, AcrdG, 
4-HNEdG and M1dG were detected in animals exposed to the ternary mixture, but not the 
TCDD treated rats compared to the control.   
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 CHAPTER I 
INTRODUCTION: OVERVIEW OF ROS-INDUCED DNA DAMAGE, VINYL 
CHLORIDE (VC) AND POLYHALOGENATED AROMATIC HYDROCARBONS 
(PHAHS) 
 
A. ROS, DNA DAMAGE AND MUTATION 
          
         Oxidative stress was defined in 1991 as “an imbalance of oxidants and antioxidants 
in favor of the former” (1). It can induce considerable amounts of reactive oxygen species 
(ROS) in vivo, which have the ability to permanently alter the structure and even the 
function of biomolecules. Under conditions of oxidative stress, DNA has received the 
most study in terms of oxidative damage among all potential targets for ROS (2-10). ROS 
can react with DNA directly and form various DNA lesions. One of the most studied 
types of DNA damage is 8-hydroxyl-2′-deoxyguanosine (8-OHdG), as shown in figure 
1.1. It is formed in relatively high amounts in vivo with background concentrations 
around 1/106 guanine (11). ROS can also abstract a hydrogen atom from polyunsaturated 
fatty acids to initiate lipid peroxidation (LPO) and produce multiple relevant adducts. The 
most well-studied DNA adducts induced by LPO are exocyclic adducts with a five-
member ring (etheno adducts) or a six-member ring (propano adducts) attached to DNA 
bases, as depicted in figure 1.1, including 1, N6-etheno-2’-deoxyadenosine (εdA), 3, N4-
etheno-2’-deoxycytidine (εdC), 1, N2-etheno-2’-deoxyguanosine (1, N2-εdG), and N2, 3- 
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ethenoguanine (N2, 3-εG), 3-(2-deoxy-β-D-erythropentofuranosyl) pyrimido[1,2-α]purin-
10(3H)-one (M1dG) and  1, N2-propano-2’-deoxyguanosine generated from acrolein, 
crotonaldehyde and 4-hydroxy-2-nonenal (4-HNE). The specific chiral isomers for 
propano-derived DNA adducts are shown in figure 1.2. 
 
         The accumulation of ROS-induced DNA adducts was shown to potentially 
represent a hazard in vivo because of its association with mutagenesis (2-10). Site-
directed mutagenicity studies found that many can induce specific transition and/or 
transversion point mutations in bacteria and/or mammalian cells, as shown in table 1.1. 
The promutagenicity of etheno DNA adducts was further demonstrated by studying their 
behavior in vinyl chloride (VC) exposed humans and animals (13, 14). Genetic changes 
similar to those induced by VC induced DNA adducts were demonstrated in p53 and H-
ras genes in animal and human angiosarcomas.  The presence of 8-OHdG during DNA 
replication can cause G to T transversions (8). Replication of MDA-modified single-
stranded M13 genomes in E coli caused G→T, A→G, and C→T mutations (9, 15). M1dG 
is the predominant DNA adduct formed by MDA in vivo. The mutagenic properties of γ-
AcrdG have been investigated in E. coli in three independent studies and the mutations 
(G→T transversion) were consistently observed at very low frequencies (<0.1%) or not 
detected at all (16-18). α-AcrdG was found to be moderately mutagenic in COS-7 and 
XPA cells (19, 20). The mutagenicities of (6R, 8R) - and (6S, 8S)-CrdG were similar in 
COS-7 system, with G→T transversions as the dominant mutations (21). Although 4-
HNE was inactive in bacterial mutagenesis assays, it caused mutations in Chinese 
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hamster lung cells and human lymphoblastoid cells with G→T transversions as the most 
prevalent base changes (22, 23).   
  
B. THE DETECTION OF ROS-INDUCED DNA ADDUCTS AND THEIR 
CONNECTION WITH DISEASE 
 
         Many different methods have been developed to detect ROS-induced DNA adducts. 
For etheno adducts, the dominant detection technique is the 32P-postlabeling method, 
which has been successfully applied to measure εdA and εdC in rodent and human tissues 
(24). Persistent increases of εdA and εdC were found in premalignant target organs 
affected by various diseases, such as genetic metal storage disorders (Wilson’s disease 
and hemochromatosis), chronic pancreatitis, and chronic hepatitis (24). 8-OHdG was ever 
detected by LC-ECD (electrochemical detector), GC-MS, immunoassay and LC-MS/MS 
(25). Using different detection techniques, elevated 8-OHdG has been detected in patients 
with various malignancies, including acute leukemia, colorectal cancer, hepatic cancer, 
oral squamous cell carcinoma, and breast cancer (25-29). M1dG was measured in human 
and animal tissues by 32P-postlabling, immunoslot blot, GC-MS and LC-MS/MS 
techniques (30-32).  Higher M1dG was detected in smoking patients with lung cancer 
compared with control smokers (30). In two studies, the level of MDA–DNA adducts 
from patients with breast cancer and patients with larynx cancer have been found to be 
higher than in controls (31, 32). HPLC-32P-postlabeling has been the dominant technique 
used for the detection of propano-derived DNA adducts, but recently more studies have 
used LC-MS/MS to detect them (33-35). To date, there is still a lack of evidence for the 
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importance of propano adducts in chemical carcinogenesis or chronic inflammatory 
diseases (24). Using different techniques, the endogenous levels of these DNA adducts in 
human and rodent tissues were obtained, as depicted in table 1.2.  
 
C. DNA REPAIR PATHWAYS FOR ROS-INDUCED DNA ADDUCTS 
 
         Base excision repair (BER) is regarded as the dominant repair pathway for ROS-
induced small DNA adducts, such as 1, N6-εdA, 3, N4-εdC and 8-OHdG (36-39). It is a 
critical process for genomic maintenance, as highlighted by the possible association of 
animals deficient in BER function with biological effects, including cancer, premature 
aging and metabolic effects (40).The initial step in BER uses DNA glycosylases, which 
cleave the N-glycosyl bond between the sugar and the base, thus releasing the damaged 
base to form an abasic site, also termed apurinic/apyrimidinic (AP) site. An individual 
glycosylase may recognize more than one type of damage, and each specific modification 
may be recognized by more than one type of glycosylase, giving a degree of redundancy 
in the process. For example, OGG1 has strong specificity for 8-oxodG, but hMYH and 
hMPG can also repair this adduct (41, 42), as shown in table 1.3. Although different 
types of DNA damage require different repair mechanisms, functional overlap between 
pathways and between proteins in a pathway has been observed. Furthermore, the overall 
DNA repair system is intimately integrated with cell cycle regulation, transcription and 
replication (41). Recently it was found that besides BER, global genome repair (a type of 
nucleotide excision repair, NER) of 8-OHdG was demonstrated in hamster cells and 
several lines of evidence indicated that mismatch repair was also involved in repair of 8-
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OHdG:dA mismatches (41). Similar results were found for 1, N6-εdA (43), which could 
be repair by both BER and AlkB, a direct reversal repair pathway, as shown in table 1.3. 
At present, NER is regarded as the primary repair pathway for propano-adducts, but it is 
possible that other repair pathways are involved in their repair (10, 44). 
 
D. VINYL CHLORIDE AND ETHENO DNA ADDUCTS 
 
        VC is a colorless organic gas used almost exclusively by the plastic industry to 
produce polyvinyl chloride (PVC) and copolymers. Regarded as carcinogenic to humans 
by IARC (45), VC can induce angiosarcoma of liver in animals and humans (14). After 
metabolic activation by CYP2E1 mainly in liver, VC is transformed into an active 
metabolite, chloroetheylene oxide, which can react with DNA directly and form several 
DNA adducts, 7-(2-oxoethyl)guanine (7OEG), and the minor adducts, 1, N6-εdA, N2,3-εG 
and 3,N4-εdC (46-49), as shown in figure 1.3. Because all these etheno-adducts are 
promutagenic, it is possible for them to cause base-pair substitution mutations in key 
cancer genes in vivo, if not repaired before cell replication. Several changes of oncogenes 
and tumor suppressor genes were reported in humans and animals exposed to VC, which 
would be consistent with the promutagenic properties of those DNA adducts (50-57). The 
accumulation of such mutations could further contribute to the formation of cancer. 
 
         Besides chemical exposures as exogenous sources, these etheno adducts can also be 
formed by lipid peroxidation induced by oxidative stress, which is the source of identical 
endogenous adducts in cells (14). Several lipid peroxidation products play an important 
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role during this process, such as 4-HNE. Because of the existence of these background 
etheno adducts, it is impossible to differentiate adducts arising from VC and those formed 
endogenously. In this study, exposure of rats to 13C labeled VC will be utilized to 
distinguish endogenous NA- from exogenous (13C2)-1, N6-εdA. The distribution of 
both NA- and (13C2)-1, N6-εdA and the persistence of (13C2)-1, N6-εdA will be 
evaluated in the primary target (liver) and non-target organs of rats. By this study, 
the reliability of nanoUPLC-MS/MS will be evaluated, which will applied to detect 
other LPO-induced adducts in animal tissues exposed to other superfund chemicals. 
 
E. TCDD, OXIDATIVE STRESS AND ROS-INDUCED DNA DAMAGE 
 
         TCDD is a persistent organic pollutant (POP), which is widespread in the 
environment and formed as an unwanted by-product during many anthropogenic 
activities (58). It has been shown to act as a multi-site carcinogen and a very potent tumor 
promoter in rodents, but has very weak initiating activity (58). The central event that 
triggers the biological effects of TCDD is thought to be its binding to a receptor protein, 
aryl hydrocarbon receptor (AhR), and subsequently, the ligand-receptor complex binds to 
the AhR nuclear translocator (ARNT), and is transported to the nucleus, where it binds to 
DNA, triggering the expression of a variety of genes, especially CYP450, as shown in 
figure 1.4 (59). The up-regulation of these enzymes may greatly speed up the oxidative 
transformation of endogenous and exogenous compounds in the body and induce ROS, 
and oxidative DNA damage. The accumulation and persistence of ROS damage may 
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contribute to the toxic effects of TCDD, since TCDD is not readily metabolized and can 
result in a prolonged and amplified response. 
 
         The relationship between oxidative stress and the toxicity of TCDD and its 
congeners has been studied since the 1980’s (60). Scientific studies indicated that TCDD-
mediated activation of the AhR changed the cellular redox balance to produce an 
oxidative stress response in liver (60-63). Hepatic lipid peroxidation induced by TCDD 
occurred at low doses (500ng/kg) in C57BL/6 mice, which carry the high-affinity Ahrb1 
allele, and only at higher doses (5 µg/kg) in DBA/2 mouse which has a low-affinity allele 
(64). In addition, inactivation of aconitase activity, a reliable measure of oxidative stress 
(65), was documented in C57BL/6 but not in DBA/2 mice following TCDD treatment 
(62). For this reason it has become widely hypothesized that the toxicity induced by 
TCDD involves an oxidative stress component; an observation that has been reported by 
several laboratories (60, 66-70). In the review written by Stohs, evidence indicating 
production of oxidative stress by TCDD in rodents was summarized, which included 
enhanced in vitro and in vivo hepatic and extrahepatic lipid peroxidation; increased 
hepatic and macrophage DNA damage; increased urinary excretion of malondialdehyde; 
decreased hepatic membrane fluidity; decreased glutathione, nonprotein sulfhydryls, and 
NADPH content in the liver (60). Although most of these studies were acute or 
subchronic studies, several relevant chronic studies were also reported. All of them 
focused on the oxidative stress in the liver of female Sprague-Dawley rats, which is a 
sensitive strain and gender with high hepatic tumor incidence after TCDD exposure. 
Tritscher et al. (68) first reported increased 8-OHdG in livers of TCDD treated intact and 
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not ovariectomized female rats after diethylnitrosamine (DEN) initatiation. Wyde et al. 
(69) further found the induction of hepatic 8-OHdG by TCDD in rats after DEN initiation 
was female-specific, estrogen-dependant and was a chronic effect. Recently, Hassoun et 
al. (67) observed increased production of superoxide anion, lipid peroxidaiton and DNA 
single-strand breaks in hepatic tissues of rats after 30 weeks of exposure to TCDD. All 
these studies supported the importance of oxidative DNA damage in carcinogenesis of 
TCDD.  
 
         Meanwhile, it was also found that TCDD dose and tissue concentration did not 
necessarily correlate with ROS production. An acute oral dose of TCDD (0.001 to 100 
µg/kg) administered to C57BL/6 mice induced a significantly sustained increase in liver 
superoxide anion and thiobarbituric acid reactive substance (TBARS) only at the highest 
dose (100 µg/kg), and resulted in hepatic TCDD concentrations of 321 ng/g at 13 weeks 
post exposure (83). In comparison, subchronic TCDD administration (0.15 to 150 ng/kg; 
5 days/week for 13 weeks) produced significantly increased superoxide and TBARS only 
with the highest (150 ng/kg/day) exposure level, corresponding to TCDD concentration 
of 12 ng/g in liver (83). Following a dosing regimen capable of producing an oxidative 
stress response, TCDD did not alter the mutation frequency or the mutation spectrum of 
the lacI transgene in male or female Big Blue rats (70). Recently, studies found that 
oxidative stress response genes were not activated in livers of animals exposed to 100 
ng/kg TCDD for 14 weeks, although significant induction of CYP450 and hepatocyte 
hypertrophy were found in the liver of these animals (71). 
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        In summary, the contribution of ROS to the toxic effects of TCDD is still 
controversial. Further scientific studies are necessary to explore whether oxidative stress 
is important or just a hypothesis of scientists to explain the complicated mechanisms for 
the toxic effects of chemicals. Because of the high propensity for artifact formation 
during sample processing, 8-OHdG can be a problematic biomarker for ROS-induced 
DNA damage. Different DNA adducts have different formation and repair pathways, 
which may result in different toxicities/responses in treated animals. Therefore, in this 
study, a battery of ROS-induced DNA adducts will be applied to further evaluate 
ROS-induced DNA damage in a two-stage initiation-promotion rat liver model with 
DEN as the initiator and TCDD as the promoter (69). This information will help us 
better understand the mode of action of hepatocarcinogensis of TCDD in female rats. 
 
F. PHAHs, TOXIC EQUAVELENCY FACTOR, OXIDATIVE STRESS AND 
OXIDATIVE DNA DAMAGE  
 
         PHAHs consist of a large class of compounds including polychlorinated 
dibenzodioxins (PCDDs), polychlorinated dibenzofurans (PCDFs), and polychlorinated 
biphenyls (PCBs) (58). They are one of the most prevalent groups of pollutants in the 
environment. PCDDs and PCDFs have no industrial use but are produced as unwanted 
by-products of many anthropogenic activities, such as chlorine bleaching of paper and 
pulp (73). PCBs were commercially produced and widely used for various industrial 
purposes, including heat transfer agents, dielectric insulating fluids for capacitors and 
paint additives (74). Because these compounds are resistant to degradation and persistent 
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in the environment, they accumulate in tissues. Humans and wildlife animals are exposed 
daily to complex mixtures of these chemicals, primarily via trace amounts present in food, 
resulting in chronic lifetime exposure which may evoke toxicity and carcinogenicity (74).  
 
        Depending on the location and type of halogenation, some PHAHs induce a similar 
spectrum of biochemical and toxic responses in experimental animals characterized by 
severe weight loss, thymic atrophy, hepatotoxicity, immunotoxicity and enzyme 
induction (58). These common biological effects are mediated through a similar 
mechanism of action as described for TCDD binding to AhR, as shown in figure 1.4. 
Therefore, these structurally related compounds are commonly referred to as dioxin-like 
compounds (DLCs) (58, 74). Due to similarity in toxicity and mechanisms of DLCs, the 
concept of the Toxic Equivalency Factor (TEF) has been used for the assessment of risk 
and regulatory control for these compounds. The TEF methodology is a relative potency 
scheme determined from the toxicity of each congener relative to that of TCDD on the 
basis of available in vivo and in vitro data. This allows for the estimation of the potential 
dioxin-like activity of a mixture of DLCs that are found in environment (74, 75), as 
shown in the following equation. 
∑∑ ∑ ×+×+×= ni niini ni niinii TEFPCBTEFPCDFTEFPCDDTEQ )()()(  
where i= the individual congener and its respective TEF, and n = all congeners within 
each class of DLCs. 
 
         Similar to the studies on the connection between ROS and TCDD, several studies 
reported the induction of ROS in hepatic tissues of rats exposed to PHAHs. Hassoun 
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found the production of superoxide anion, lipid peroxidation and DNA SSBs in liver 
DNA of rats after exposure to various mixtures of TCDD and two of its congeners, 
PeCDF and PCB 126 for 13 weeks (67). Other chronic animal studies demonstrated the 
involvement of ROS in the toxicity and carcinogenicity of PHAHs (77). 
 
        Recently, in an effort to evaluate the TEF methodology for the chronic toxicity and 
carcinogenicity of DLCs and structurally related polychlorinated biphenyls (PCBs), the 
National Toxicology Program (NTP) conducted a series of 2-year bioassays in female 
Harlan Sprague-Dawley rats exposed to DLCs (such as TCDD, PCB 126, and PeCDF 
and non-dioxin-like compounds (NDLCs) PCB153). The toxic effects of the ternary 
mixture of TCDD, PCB126 and PeCDF and the binary mixture of PCB126 and PCB153 
were also evaluated in these studies. Besides inducing a high incidence of hepatic tumors 
in female rats, chronic inflammation in liver tissues was also observed in the exposed 
animals. Since the DNA damage caused by ROS has been implicated in a myriad of 
diseases, it is reasonable to hypothesize that ROS-induced DNA damage is an 
important mode of action for carcinogensis of these PHAHs, which can be estimated 
by TEF approach, as shown in figure 1.5. 
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Figure1.1 Major DNA adducts induced by reactive oxygen species (ROS) 
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Figure 1.2 Major propano-derived adducts induced by lipid peroxidation (LPO) 
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Figure 1.3 Etheno DNA adduct formation in VC exposed animals 
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Figure 1.4 Oxidative DNA damage induced by dioxin-like compounds (DLCs) 
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Figure 1.5 Hypothetical schemes for the role of cumulative oxidative stress in 
carcinogenesis 
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Table 1.1 Single-base changes induced by ROS related DNA adducts in the site-directed 
mutagenesis experiments 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ROS-induced 
DNA lesions In vitro In E. coli In mammalian cells 
1, N6-εdA A>G, A>T, A>C (2) 
A>G, A>T, A>C 
(3, 4) A>G, A>T, A>C (4) 
3, N4-εdC  C>T, C>A (3) C>T, C>A (3) 
1, N2-εdG  G>T, G>A (5) G>T (5) 
N2, 3-εG G>A (6) G>A (7)  
8-OHdG G>T (8) G>T (8) G>T (8) 
MDA induced 
adducts G>T, G>A (8)
 
 G>T, G>A (9) 
AcrdG  G>T (γ) (10) G>T, G>A, G>C (γ+α) (10) 
CrdG   G>T, G>A, G>C (10) 
HNEdG   G>T (10) 
 
 
 18 
 
Table 1.2 Reported endogenous amounts of ROS-induced DNA adducts 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   DNA adduct Background level 
8-OHdG (24) 20-200/108 dNs in human lymphocytes 
N2, 3-εG (24) 1.5-17.5/108 dNs in human liver and unexposed rats 
1, N6-εdA (24) ND-0.7/108 dNs in rats, mouse and human tissues 
3, N4-εdC (24) ND-2.7/108 dNs in animals and human tissues 
1, N2-εdG (79) 2.0-3.9/108 dNs in mice (liver, spleen and kidney) 
M1dG (24) 0.8-1.8/108 dNs in animals, 0.2-110/108 dNs in human 
AcrdG (24, 33, 34, 
79) 
1.4-23.3/108 dNs in rat tissue (brain, lung, kidney, colon, 
prostate, mammary, leukocytes); 0.25-50/108 dNs in human 
tissue (liver, breast, leukocytes, brain, gingival) 
CrdG (24, 79) 
0.2-9.9/108 dNs in rat tissue (brain, lung, kidney, colon, 
prostate, mammary, leukocytes); ND-7.5/108 dNs in human 
tissue (liver, lung and gingival)  
HNEdG (24, 35, 80) ND-15.8/10
8
 dNs in rats (liver, kidney, lung, colon, 
forestomach), 2-60/108 dNs in human brain and colon tissue 
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     Table 1.3 Reported repair pathways for ROS-induced DNA adducts 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
DNA 
lesions Bacterial enzyme/system Mammalian enzyme/system 
1, N6-εdA AlkA (38), AlkB ANPG/Aag (39) (BER), ABH2 (43) (direct reversal pathway) 
3, N4-εdC AlkB (81) mismatch-specific thymine-DNA glycosylase (82) (BER) 
1, N2-εdG  ANPG (39) (BER) 
N2, 3-εG E.Coli 3-methyladenine DNA glycosylase (39) (BER)  
8-OHdG MYH, MMR 
8-oxoguanine DNA glycosylase 
(42) (OGG1), hMYH, hMPG, 
hNEIL1 (BER), MMR, NER 
M1dG NER (10)  
AcrdG NER (10)  
CrdG NER (10)  
HNEdG NER (44), HR (44) NER (10) 
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CHAPTERII 
DETECTION OF ROS-INDUCED DNA ADDUCTS BY LC-MS/MS 
 
A. INTRODUCTION 
 
         Oxidative stress is a common state in pathophysiology, where the number of 
reactive radicals or molecules being formed exceeds those being detoxified. It is regarded 
as playing an important role in many diseases including cancer, neurodegeneration and 
aging (1). Reactive oxygen species induced by oxidative stress can react with DNA 
directly and form various DNA lesions. Among them, the most studied is 8-hydroxyl-2′-
deoxyguanosine (8-OHdG). Persistent oxidative stress can also induce excessive lipid 
peroxidation products (LPO), especially unsaturated aldehydes, which are particularly 
reactive in forming exocyclic DNA adducts (2). The primary exocylic adducts are a five-
membered ring (etheno adducts) or a six-membered ring (propano adducts) attached to 
DNA bases. The major etheno adducts include 1, N6-etheno-2’-deoxyadenosine (1, N6-
εdA), 3, N4-etheno-2’-deoxycytidine (3, N4-εdC), 1, N2-etheno-2’-deoxyguanosine (1, N2-
εdG) and N2, 3εG. The dominant propano adducts include acrolein, crotonaldehyde and 
4-HNE-derived dG adducts, assigned as AcrdG, CrdG, and HNEdG respectively. Based 
on the direction of the Michael addition of those α, β-unsaturated aldehydes with β 
substituents, various stereoisomers of pronano adducts exist (3). Those ROS-induced 
adducts can cause base-pair substitution mutations and have been applied as valuable
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biomarkers for assessing oxidative stress-derived DNA damage (2-3). With the 
development of sensitive and robust detection techniques, growing evidence supports that 
these DNA adducts are significantly induced in patients with various chronic 
inflammation diseases including cancer (2, 4-9). 
 
         To date, many different methods have been developed to detect ROS-induced DNA 
adducts. As one of the most studied adducts, 8-OHdG was measured in animal or human 
tissues by multiple techniques, including LC-ECD (electrochemical detector), GC-MS, 
immunoassay, 32P-postlabeling and LC-MS/MS (8). However, lack of consistency was 
observed in the results obtained by different methods, sometimes by up to two or three 
orders of magnitude. Therefore, the European Standards Committee on Oxidative DNA 
Damage (ESCODD) evaluated several different methods and found that LC-ECD, instead 
of LC-MS/MS, was a reliable, sensitive, and precise procedure for 8-OHdG detection 
(10). However, only limited laboratories used LC-MS/MS and no sample purification 
was performed before detection in their studies. The recent rapid development of LC-
MS/MS has greatly promoted its application in the detection of DNA adducts (11-13). 
Thus, it is still worthwhile to develop an assay for the detection of 8-OHdG by LC-
MS/MS. 32P-postlabeling assay has been the most widely applied technique for 
quantitative analysis of LPO-induced DNA adducts (14-18). The background 1, N6-εdA 
and 3, N4-εdC were first detected in tissues of control animals by an ultrasensitive, 
specific immunoaffinity 32P-postlabeling method (14). The adduct concentrations 
measured by this method were found to be in good agreement with those determined by a 
radioimmunoassay. The small DNA amount consumption, ~10µg, made this method 
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especially valuable for epidemiology studies (14). At present, most propano adducts in 
animal tissues are detected by a HPLC-32P-postlabelling method (15, 16). With LC 
sample purification, this assay can differentiate the stereoisomers of propano adducts. In 
general, the amount of DNA required was more than 100 µg. Recently, several studies 
reported the detection of propano adducts in human samples by LC-MS/MS (19-22). 
Using a capillary LC-MS/MS system, higher sensitivity was obtained in these studies 
(19-22).  Because the measurement of M1dG was affected by the competitive reaction of 
pH-dependent ring-opened formation of N2-(3-oxo-1-propenyl)-deoxyguanosine anion 
(N2OPdG-), most studies chose M1G as the target molecule for assay development (23, 
24). 32P-postlabeling was the first method employed for the detection and quantitation of 
M1G using 10 µg DNA (17), followed by GC/MS with electron capture negative 
chemical ionization detection and LC-MS/MS with chemical derivatization (17, 25-29).  
However, most of these assays were time-consuming and required extensive sample 
manipulation by highly skilled personnel.  
 
         In this study, a series of assays were developed for the detection of ROS-induced 
DNA adducts. The general strategy for assay development is shown in figure 2.1. Based 
on the physicochemical properties of these DNA adducts, enzymatic hydrolysis, LC 
sample purification and MS detection were optimized. The processing time of 8-OHdG 
was minimized and antioxidant, 2, 2, 6, 6-tetramethyl-piperidinoxyl (TEMPO, 20mM 
final concentration) was added to samples to minimize artifactual formation of 8-OHdG. 
A nanoUPLC-MS/MS system with column switching was applied to measure all LPO-
induced DNA adducts. These assays will help us explore the comprehensive spectra of 
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oxidative DNA damage in animals with chronic inflammatory diseases after chemical 
exposure in the future. 
 
B. MATERIALS AND METHODS 
 
Chemicals  
         Nucleic acid purification grade lysis buffer, protein precipitation solution and 
Proteinase K were purchased from Gentra Systems (Minneapolis, MN). TEMPO was 
obtained from Acros (Morris Plains, NJ). Other chemical reagents including 1, N6-εdA 
and 8-OHdG standards were from Sigma-Aldrich Chemical Company (St Louis, MO). 
HPLC grade water, methanol and other chemical solutions were purchased from Thermo 
Fisher Scientific Company (Raleigh, NC). [15N5]-8oxodG standard, [15N5]-dG, [15N3]-2′-
Deoxycytidine, and [13C10]-2´-deoxyguanosine was purchased from Cambridge Isotope 
Laboratories (Andover, MA, USA).  
 
Instrumentation 
         HPLC purification of the synthesized standards was performed on an Agilent 
(Agilent Technologies, Palo Alto, CA) 1100 series with a Hewlett-Packard 1040A diode 
array detector. Standard characterization by full scan of tandem mass spectra and the 
detection of 8-OHdG were done on a Finnigan Quantum triple-quandrupole mass 
spectrometer (ThermoFinnigan, San Jose, CA) connected to Waters UPLC system 
(Waters, Milford, Massachusetts). All LPO-induced adducts were measured by a 
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nanoUPLC-MS/MS system, comprised of a 10 kpsi nanoacquity Ultra performance LC 
system and a TSQ-Quantum ultra triple quad mass analyzer. An Agilent 1200 Series 
analytical fraction collector system was used for the LC sample purification of ROS-
induced DNA adducts. 
 
Animal exposure 
        The livers of Shasta strain rainbow trout (O. mykiss) exposed to DBP were from 
OSU Sinnhuber Aquatic Research Laboratory (SARL). The animal protocols were 
describled in detail previously (88).  Trout fry (1.5g) were fed standardized OTD with 
different levels of DBP incorporated. On days 29, fish were sampled from tank for 
analysis of DNA adducts. 
 
        Male wide type and XPA null (XPA-/-) mice were dosed with olive oil (10ml/kg) or 
carbon tetrachloride (1600 mg/kg) by intraperitoneal injection for 13 days. After the 
treatment, these animals were sacrificed and livers were harvested. 
 
        The animal protocol for PHAHs treated female Sprague-Dawley rats (Harlan 
Sprague-Dawley Inc., Indianapolis, IN) was described in detail in the technical reports 
from NTP (89). Briefly, female Sprague-Dawley rats received the corn oil:acetone (99:1) 
vehicle at the age of aaproximately 8 weeks old for 53 weeks. After exposure, these 
animals were sacrified by carbon dioxide asphyxiation. 
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DNA isolation 
         The DNA isolation protocol was slightly modified from Jeong’s study (90). Briefly, 
~300 mg liver DNA was thawed and homogenized in ice-cold PBS solution. After 
centrifugation for 15 min at 1000g and washing by PBS buffer, the nuclear fraction was 
collected and reconsitituted in 6 ml lysis buffer. Protein was removed by incubation with 
proteinase K (400 U/ml, 60 µl) overnight at 4 ˚C and extracted twice with 6ml 70% 
phenol solution. The nuclear acid was precipated from the sample by adding 300 µl 3 M 
NaCl and 12 ml cold ethanol, followed by centrifugation and rinsing by 70% ethanol. 
After reconstitution in PBS buffer, the samples were incubated with RNase A (0.8 
KeU/ml) and RNase T1 (3 mU/ml) for 1h at 37 ˚C. Finally, the DNA was precipated 
from the sample by the sequential addition of 100 µl 3 M NaCl and 4 ml cold ethanol, 
and rinsed with 70% ethenal after centrifugation. After the sample was reconstituted in 
HPLC water, the concentration and purity of the DNA was measured by UV. 
 
Standard synthesis 
         
15N5-1, N6-εdA standard was synthesized and characterized as described by Ham et 
al. (30). 15N5-2΄-deoxyadenosine (15 mg) and ClCH2CHO (8 M) were added in a solution 
of ammonium formate (420 mg) in water (7 ml) and ethanol (3 ml). The contents were 
stirred at 40 ˚C for 7 h followed by cooling to room temperature and neutralization to pH 
7 with sodium bicarbonate. The solvent was evaporated at room temperature using argon 
gas. The product was dissolved in chloroform/methanol (4:1, 10 ml) and purified on 
silica gel. 15N5-εdA was eluted by a mixture of chloroform (80%) and methanol (20%), 
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followed by purification by HPLC on a C18 column.  The purity of the final product was 
verified by UV, NMR and mass spectrometry. 
 
         1, N2-εdG and 13C10-1, N2-εdG were synthesized based on the report of Kusmierek 
et al. (31). Chloroacetaldehyde (57 µmol) was added into the stirred solution of N, N′-
dimethylformamide (166 µl) with 10 mg [13C10]-2′-deoxyguanosine or 2’-
deoxyguanosine (34 µmol) and 7 mg K2CO3 (50 µmol). After reacting for 3 h at room 
temperature, K2CO3 (33.3 µmol) and chloroacetaldehyde (33 µmol) were added and 
stirred for an additional 12 h. The product was purified by LC (C18 column, 250 × 4.6 
mm; 4µ). Solvent A was methanol; solvent B was 0.5 M NH4HCO3 in water. The flow 
rate was 1000 µl/min. The elution time of 1, N2-εdG and 13C10-1, N2-εdG was verified by 
UV and the purity was determined by mass spectrometry and NMR. 
 
         Malondialdehyde (MDA) modified 15N- or natural abundance (NA-) DNA was 
made based on Jeong’s study (28). Briefly, MDA was prepared from 
tetramethoxypropane in 1 M HCl by hydrolysis at 45 ˚C for 45 min. 15N-DNA was 
prepared using E. coli cultured in minimum salt medium containing (15NH4)2SO4 as a 
single nitrogen source for bacterial growth. 3 mg 15N- or NA-DNA was incubated for 2 h 
in cold room (4 ˚C) with 6 ml of an aqueous solution containing 50 mM MDA as IS or 
AS DNA. Excess MDA was removed by precipitating DNA using ethanol and water. 
15N5 or NA-M1dG in DNA was determined by measuring M1G concentration using 
HPLC with fluorescence detection (Applied Biosystems, Foster City, CA) after acid 
hydrolysis of DNA.  
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         The standards for AcrdG, CrdG and 4-HNEdG and their 15N5 labeled internal 
standards were synthesized based on previous studies (21, 32, 33). In brief, 1 ml of 400 
mM acrolein, crotonaldehyde or 4-HNE were allowed to react with dG or 15N5-dG (50mg) 
in 10 ml of 0.02 M phosphate buffer (pH = 7) at 37 ˚C overnight. Then 200 µl of 4 M 
acrolein, crotonaldehyde or 4-HNE was added into the sample and incubated at 37 ˚C 
overnight followed by two extractions with 10 ml chloroform and solvent evaporation 
using argon gas. The products were further purified on C18 column (150 mm × 4.6 mm, 
5 µm) by HPLC using PDA detector with separate collection of the stereoisomer. The 
product peak was verified by UV spectrometry and mass spectrometry.  
           
Enzymatic digestion and HPLC purification 
         Three different enzymatic systems were evaluated for 1, N6-εdA detection (30, 34, 
35). Method A (30): 100 µg DNA was incubated in Tris buffer (pH 7.0, 80 mM Tris-Hcl, 
20 mM MgCl2) with DNaseI (200 U) for 10 min at 37 ˚C. Alkaline phosphatase I (AP, 10 
U) and phosphodiesterase I (PDE, 0.013 U) were added into the sample for additional 1 h 
incubation at 37 ˚C. Method B (34): 100 µg DNA was incubated at 37 ˚C for 3 h in 
sodium acetate buffer I (sodium acetate 30 mM, pH 5.6, 0.2 mM zinc chloride) with 5 µg 
of nuclease P1 (NP1), followed by an additional 6 h incubation with 520 µl of sodium 
acetate buffer II (sodium acetate 30mM, pH 8.1), 20 U of AP and 0.01 U of PDE. Method 
C (35): micrococcal nuclease (2 U) and spleen phosphodiesterase (0.2 U) were added into 
40 mM sodium succinate buffer (20 mM calcium chloride, pH 6) to digest 100 µg DNA. 
After a 4 h incubation at 37 ˚C, NP1 (5 µg) was added for an additional 2 h incubation. 
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After DNA hydrolysis, the samples were purified on an Atlantis T3 column (4.5×150 mm, 
5 µ).  Solvent A was 10 mM ammonium acetate in water; B was 100% methanol. The 
initial condition was 5% B at a flow rate of 1 ml/min for 10 min. Then solvent B 
increased to 10% in the next 5 min, 20% in 10 min and 80% in 13 min and return to the 
initial condition 5% in the last 5 min.  
 
         50 µg DNA was processed with TEMPO (5µl, 1.5mM) added at the beginning of 8-
OHdG assay. The same enzymatic hydrolysis as 1, N6-εdA was applied to digest DNA. A 
short LC purification method was developed especially for 8-OHdG using the same LC 
columns and mobile phases as 1, N6-εdA. The gradient program was as follows: solvent B 
was 15% for the initial 5 min, increased to to 30% in 20 min and 80% in 10 min before 
returning to 15% in 5 min. The LC flow rate was 0.6 ml/min. 
 
         Two digestion systems were evaluated for the measurement of propano adducts. 
System A consisted of DNase I, PDE and AP in Tris buffer (30). The incubation time was 
the same as method A for 1, N6-εdA. System B was composed of DNase I, NP, PDE and 
AP in sodium acetate buffer (34, 36). The same optimized incubation time for 1, N6-εdA 
detection was applied for these adducts. 200U DNase I was added into the sample with 
NP1 at the beginning of the digestion. Calf thymus DNA (ctDNA) treated by acrolein, 
crotonaldehyde or 4-HNE was digested by both of these systems. CrdG and 4-HNEdG 
were processed together with 10 mM ammonium acetate in water as solvent A and 
methanol as solvent B. With LC flow rate of 0.7 ml/min, solvent A was 65% for the 
initial 5 min, decreased to 30% in 15 min and kept stable for 10 min before returning to 
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65% in 5 min. For simultaneous purification of AcrdG, M1dG and 1, N2-εdG, the mobile 
phases were 5 mM ammonium formate and 0.1% formic acid in water (pH 3.5) as solvent 
A and methanol as solvent B. The flow rate was 0.6 µl/min. Solvent B was 10% for the 
initial 8 min, increased to 30% in 12 min and kept stable for 10 min before returning to 
10% in 5 min.  
 
LC-MS/MS detection 
         Three LC-MS/MS systems were evaluated for 1, N6-εdA detection, UPLC-MS/MS, 
capillary LC-MS/MS and nanoUPLC-MS/MS. In nano UPLC-MS/MS, a nanoacquity 
symmetry trap column (180µm×20mm, 5 µm), was connected with a nanoUPLC BEH 
C18 analytical column (1.0mm×100mm, 1.7µm) through a control valve. UPLC and 
capillary LC-MS/MS systems consisted of an Aquity UPLC system or Agilent 1200 
capillary system and a TSQ triple quadrupole mass spectrometer. In the UPLC system, 
0.1% formic acid in water was solvent A and 0.1% formic acid in methanol was solvent 
B. The flow rate was 200µl/min. A HSS T3 UPLC (1.8 µm, 2.1×100 mm) column was 
used to purify the samples before MS detection.  In capillary system, the separation was 
performed on a ZORBAX SB-C18 column (100mm×0.5mm, 3 µm) with the flow rate of 
7µl/min. Solvent A and B were 5mM ammonium formate in water and methanol 
respectively. The same collision energy and transitions were applied in all the three 
systems. 1, N6-εdA was detected under multiple reaction monitoring (MRM) in the 
positive ESI mode, m/z 276.0 → 160.0 for 1, N6-εdA and m/z 281.0 → 165.0 for 15N5-1, 
N6-εdA. The capillary temperature was set as 285 ˚C. The spray voltage was 2000 V in 
nano and capillary system, and 2800 V in UPLC system. The collision energy (CE) was 
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16 eV. The sheath and auxillary gas pressure was 35 and 30 Torr respectively in UPLC 
systems, but none of them was used in capillary or nano system. 
 
         8-OHdG was detected by UPLC-MS/MS on a T3 HSS column (2.1×100mm, 1.7 µ) 
with 0.1% acetic acid in water as solvent A and methanol as solvent B at flow rate of 
200µl/min. The gradient program was as follows: solvent B was increased from 1% to 
5% in 2 min, held at 5% for 10 min, and increased to 50% in 2 min. m/z 284.1 → 168.0 
and m/z 289.1 → 173.0 were monitored for 8-OHdG and [15N5]8-OHdG respectively with 
CE 12 eV. The spray voltage was 3000 V. The vaporizer temperature was 250 ˚C. The 
sheath and auxillary gas pressure was 35 and 30 Torr respectively. The capillary 
temperature was 285 ˚C. 
 
         NanoLC-MS/MS was used to detect all LPO-induced DNA adducts. For the 
detection of 1, N2-εdG, M1dG, CrdG, 4-HNEdG and AcrdG, solvent A and B were 0.1% 
formic acid in water and acetonitrile respectively. The sample was first loaded on the trap 
column by 99% A for 3 min with flow rate of 5µl/min. For 1, N2-εdG, M1dG, and AcrdG 
detection, solvent B was 5% for the initial 1 min, followed by a increase to 30% in 10 
min before returning to 5% in 15 min. For CrdG detection, solvent B was 10% for the 
initial 5 min, increased to 50% in 10 min and kept stable for 5 min. For 4-HNEdG 
detection, solvent B was 15% for the initial 2 min, increased to 70% in 10 min and 
returning to 15% in 10 min. The flow rate was 1.0 µl/min for the detection of all above 
adducts. Similar MS parameters were used to detect 1, N2-εdG, M1dG, AcrdG, CrdG and 
4-HNEdG except different transitions were observed by MRM. The capillary temperature 
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was set as 285 ˚C. The spray voltage was 1500 V. Neither nebulizing nor drying gas was 
used in this system. Two transitions were monitored for the detection of 1, N2-εdG, M1dG 
and 4-HNEdG respectively with CE 16 eV, m/z 304.0 → 188.0 and 308.0 → 193.0 for 
M1dG and [15N5]-M1dG, m/z 292 → 176.0 and 302 → 181.0 for 1, N2-εdG and [13C10]-1, 
N2-εdG, and m/z 424.0 → 308 and 429.0 → 313.0 for 4-HNEdG and [15N5]-4-HNEdG. 
Three and four transitions were monitored for CrdG and AcrdG detection respectively, 
m/z 338 → 222 with CE 12 eV and m/z 338 → 178 with CE 32 eV for CrdG, 343 → 227 
with CE 12 eV for [15N5]-CrdG, m/z 324 → 208 with CE 12 eV and 324 → 164 with CE 
32 eV for AcrdG, 329 → 213 with CE 12 eV and m/z 329 → 190 with CE 32 eV for 
[15N5]-AcrdG. 
 
C. RESULTS 
 
Enzymatic hydrolysis and HPLC purification 
         In comparing method A, B and C for the detection of 1, N6-εdA, less interference 
was found in system B and C than A. Because of the convenience of sample processing 
for method B, it was selected for further optimization. By evaluating the concentrations 
of dA and 1, N6-εdA in ctDNA, the final incubation time was adjusted to be 2 hours in 
method B. Using the optimized incubation time, similar amounts of 1, N6-εdA were 
detected with 0.0118 U and 1.18 U PDE, which indicated that 0.0118 U PDE was enough 
for 100 µg DNA digestion, as shown in figure 2.2. 
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         Higher amounts of AcrdG were observed in the acrolein treated ctDNA samples 
digested by system B than A and C, although no difference was found for the amount of 
CrdG in the crotaldehyde treated samples, as shown in figure 2.3. Background noise 
appeared for the detection of 4-HNEdG and M1dG in control and 4-HNE or MDA treated 
ctDNA by system A. Thus, system B was selected for the assay development of propano 
adducts, 1, N2-εdG and M1dG. 200 U DNase I was added into system B at the beginning 
of digestion, because some studies mentioned that it was necessary for the detection of 
bulky DNA adducts (36). 2΄-Deoxyadenosine (dA) co-eluted with AcrdG on C18 
columns when 5 mM ammonium formate in water was used as solvent A and methanol as 
B. With 0.1% formic acid added in 5mM ammonium formate aqueous solution as solvent 
A, complete separation of dA and AcrdG was achieved, as shown in figure 2.4. The peak 
of M1dG appeared after that of 1, N2-εdG determined by LC-MS/MS using MDA-treated 
DNA. The concentration of M1dG in MDA-treated ctDNA was below the LOD of the 
UV detector of the fraction collector. The typical chromatograms for LC purification of 1, 
N2-εdG, AcrdG, 4-HNEdG and CrdG are shown in figure 2.4. The fractions containing 1, 
N6-εdA and 8-OHdG were collected based on retention time of standards on fraction 
collector, as shown in figure 2.5.  
 
LC-MS/MS detection and assay validation 
       The dynamic range of nanoUPLC system for 1, N6-εdA detection was evaluated by 
standards, as shown in figure 2.6. The limit of quantification (LOQ) was determined to be 
200 atmol on-column. Using the same standards with concentrations from 1.6 to 106 nM, 
the sensitivity of three LC-MS/MS systems was determined (the slope of the linear 
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dynamic curve), as shown in figure 2.7. The sensitivity of nanoUPLC system was more 
than 20 times higher than the UPLC system, followed by the capillary system which had 
3 to 4 times higher sensitivity than the UPLC system. After LC purification, no 
significant matrix effects were observed with the nanoUPLC system, as indicated by 
figure 2.6. Better results were also obtained for the detection of 1, N6-εdA using the 
nanoUPLC than the UPLC system when evaluating rat liver DNA exposed to (13C2)-vinyl 
chloride (VC), as depicted in figure 2.8. Transitions m/z 276 → 160, 278 → 162 and 281 
→ 165 were used to monitor endogenous NA-1, N6-εdA (lipid peroxidation induced 1, 
N6-εdA), exogenous [13C2]- 1, N6-εdA (VC induced 1, N6-εdA) and internal standard 
[15N5]- 1, N6-εdA respectively. 
 
         The typical chromatograms of 8-OHdG, 1, N2-εdG and propano adducts in ctDNA 
and their calibration curves are shown in figure 2.9 A~E. Well-shaped peaks appeared in 
each monitored transition of these adducts. With R2 ≥ 0.98, all of these calibration curves 
indicated a good linear dynamic range (from sub-femto mole to several hundred femto 
mole) for the detection of these adducts by nanoUPLC-MS/MS system. The LOQ for 
propano adducts was 50 atmol on-column, which was determined by injecting standards 
with S/N higher than 10. Using this battery of assays, the background concentrations of 
these adducts in control liver DNA of female Sprague-Dawley rats (61 weeks old) were 
determined (table 2.1).  8-OHdG had the highest concentration in these samples, followed 
subsequently by AcrdG, M1dG, 1, N2-εdG, 1, N6-εdA, 4-HNEdG and CrdG. Besides, 
M1dG, 1, N2-εdG and propano adducts were also measured in liver DNA from mice 
exposed to a single dose carbon tetrachloride (1600 mg/kg in olive oil) and trout liver 
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DNA exposed by dibenzo[α,l]pyrene (DBP). The results are shown in figure 2.10A~D. 
After i.p. exposure to carbon tetrachloride for 13 days, significant increases of M1dG, 1, 
N2-dG and AcrdG were observed in the liver DNA of wild type mice (2 to 3 fold increase 
in the exposed compared with the control), as shown in figure 2.10A. With the same 
chemical treatment, M1dG, 1, N2-εdG and AcrdG were significantly induced in liver 
DNA of exposed XPA-/- mice compared with the control, as depicted in figure 2.10B. 
Three- to four-fold increases of M1dG, 1, N2-εdG and AcrdG were present in the liver 
DNA from XPA-/- mice exposed to carbon tetrachloride, compared with exposed wide 
type mice, suggesting that NER is a dominant repair pathway for these DNA adducts. 
After 28 days exposure, no significant increases of 1, N2-εdG, M1dG, AcrdG, 4-HNEdG 
and CrdG were observed in the liver of trout treated by 80 ppm DBP, compared with the 
0.45 ppm treated group, as indicated in figure 2.10C and 2.10D. 
 
D. DISCUSSION 
 
         With background adducts usually around 1/106 guanine, 8-OHdG has been detected 
by many different techniques, including immunoaffinity assay, LC-ECD, LC-MS/MS, 
32P-postlabelling, GC-MS and formamidopyrimidine DNA glycosylase (FPG) based 
methods (10, 37-51). The main problem for 8-OHdG detection is artifact formation from 
the oxidation of unmodified guanine bases present in DNA. This may explain why there 
is a great variation in the amounts of 8-OHdG in vivo reported by different methods. GC-
MS method is often cited as overestimating the concentration of 8-OHdG in DNA 
samples due to the harsh sample processing, such as severe acidic conditions for DNA 
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hydrolysis and a lengthy derivatization step (39, 43, 50). 32P-postlabelling has the 
advantage that sub-milligram DNA samples are required, which provides unique 
advantages in biomonitoring studies of human populations (10, 39). However, it has also 
been suggested that this method may be prone to artefactual production as result of 
radiolysis of guanine residues by [32P]-ATP. The main advantage of the immunoaffinity 
method is the specificity of the antibody for recognizing 8-OHdG in DNA, which also 
determines its limits in cross-reactivity of antibody with structurally related analytes 
present in complex mixtures (10, 39, 43, 47, 48). FPG is an enzyme which recognizes 8-
OHG, as well as formamidopyrimidines (ring-opened purines resulting from oxidation). 
8-OHdG amounts are determined by measuring the DNA breaks after application of FPG, 
which convert the oxidized base to a DNA break. This method emerged in the mid-1990s 
and tended to report the lowest 8-OHdG values compared with LC-ECD and GC-MS 
methods (10). It could detect dose response curves of 8-OHdG for HeLa cells treated 
with visible light in the presence of phtosensitizer (10, 37, 39). Based on ESCOD’s 
studies, LC-MS/MS methods have not reached an acceptable standard for 8-OHdG 
detection with direct injection after enzyme digestion. However, because of the rapid 
development of sensitive LC-ESIMS/MS, several studies began to explore its application 
in 8-OHdG detection (40-51).  Sample purification before MS detection was regarded as 
a key step for the detection of DNA adducts by LC-ESIMS/MS (11, 12). The enormous 
amounts of dT and dG in the enzymatic hydrolytes can cause ion suppression, artifact 
formation and poor sensitivity, especially when they co-elute with 8-OHdG from the C18 
column using acetic acid or formic acid in water as phase A. Traditional C18 columns, 
solid phase extraction (SPE) and immunoaffinity columns were all evaluated as 
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purification techniques for 8-OHdG detection by LC-MS/MS (40-51). With LC 
purification, decent peaks of 8-OHdG were observed by LC-MS/MS and the LOQ was 
reach several fmol on-column in the present and other published studies (10, 34, 48, 49). 
However, comprehensive comparison between LC-MS/MS assay with LC-ECD with 
sample purification before injection is still necessary.  Besides the reported artifact 
formation during DNA isolation by ESCODD (37), Chao et al. found the production of 
artifacts during vacuum drying, which was supported by other reports (44, 49-51). Their 
studies indicated that as a concentration process, both vacuum and freeze drying for intact 
or hydrolyzed DNA could introduce artifact formation. With SPE purification before 
column switching LC-MS/MS detection, higher 8-OHdG was observed than the one 
without SPE, which indicated that excessive sample processing also contributed to the 
formation of artifact. In our studies, the further oxidation of [15N5]8-OHdG in samples 
was observed when offline LC sample purification was applied before LC-MS/MS 
detection, which made the quantification of 8-OHdG even more complicated. Besides, 
background 8-OHdG levels, similar to other reports (48, 49) were detected in this study. 
These results suggest that online column switching may work well for the detection of 8-
OHdG. 
 
        1, N6-εdA and 3, N4-εdC have been measured in numerous animal and human 
studies, especially in chronic inflammatory diseases, such as chronic pancreatitis and 
hepatitis, following development of an immunoaffinity-32P-postlabeling method (2, 14, 
52, 53). With low DNA amounts (~10 µg), the sensitivity of this assay can reach several 
adducts per 1010 unmodified nucleosides. The whole assay involved immunoaffinity 
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column purification, 32P-postlabelling procedure and thin-layer chromatographic 
separation. The mean 1, N6-εdA and 3, N4-εdC levels per 108 parent nucleotides in normal 
human liver were determined to be 1.9 ± 0.5 and 2.8 ± 1.0 respectively by this assay (53). 
Although it has excellent sensitivity, this assay also has shortcomings. The accuracy of 
the measurements was not well defined due to the lack of an authentic internal standard 
and no chemical structural information is provided. Compared with 32P-postlabelling 
method, mass spectrometry is a powerful technique with the particular advantage in 
providing the information on chemical structure of adducts. Using isotopically labeled 
internal standards, the entire sample processing scheme can be monitored to better assess 
the accuracy of the assay. Using various sample purification techniques, GC-MS/MS or 
LC-MS/MS has been applied to detect etheno adducts, including 1, N6-εdA or εA, 3, N4-
εdC or εC, N2, 3εG and 1, N2-εdG or 1, N2-εG (54-63). There were several steps involved 
in the detection of etheno adducts by GC-MS, including DNA hydrolysis, adduct 
derivatization, and adduct detection with selective ion monitoring (SIM) (54-57). Using 
GC/NICI (negative ion chemical ionization) /MS and C18 solid phase extraction, Chen et 
al. measured ethenoA in ctDNA. The detection limits for the entire assay could reach 6.3 
fmol after derivatization by pentafluorobenzylation (PFB) (54). Ham and Morinello 
successfully applied the similar technique in the measurement of 1, N2-εG and N2, 3εG in 
rodent DNA. Using immunoaffinity columns as the dominant purification technique, the 
limit of detection was determined to be 5 N2, 3εG adducts/108 normal dG nucleosides in 
150 µg DNA and 15 fmol 1, N2-εG in 250 µg DNA respectively (55, 56). Besides, they 
also demonstrated that neutral thermal hydrolysis and HCl hydrolysis gave higher 
detection limits than enzymatic hydrolysis (55). Because of the development of 
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electrospray interfaces and the lack of a need for chemical derivatization, LC-MS/MS has 
become more popular as a detection technique for etheno adducts (30, 34, 49, 57-66). 
Several groups have successfully developed LC-MS/MS assay for the detection of etheno 
adducts with diverse sample enrichment techniques (30, 34, 49, 57-66). With on-line 
sample processing, Churchwell et al. detected background 1, N6-εdA and 3, N4-εdC in 
commercially available ctDNA by LC-MS/MS, with the mean value of 5.8 ± 3.7 and 9.7 
± 8.2 adduct/108 unmodified nucleosides respectively (66). Their corresponding LOD 
was 10 fg and 20 fg on-column. Ham et al. applied offline immunoaffinity-LC-MS/MS in 
the detection of 1, N6-εdA in mice. The mean number of adducts in ctDNA was 
determined to be 2.0 ± 0.9 adduct/108 dA (30). Chen et al. developed a LC-MS/MS assay 
with SPE to measure εA in human urine with LOD 2pg on-column (57).   Compared with 
other etheno adducts, more LC-MS/MS assays have been developed for the detection of 1, 
N2-εdG or 1, N2-εG (34, 49, 58-63), which could be divided into online and offline LC-
MS/MS assays. Based on the different optimal collision energy between 1, N2-εG and 
N2,3-εG in MS/MS systems (the CE of 1, N2-εG and N2, 3-εG was 28 and 36 mV 
respectively ),  Müller successfully developed a LC-MS/MS assay to measure 1, N2-εG in 
2-chlorooxirane treated ctDNA with HCl hydrolysis (61). With LOD 5.8 fmol on column, 
this assay was applied to measure 1, N2-εG in a human study (62). Using a similar 
technique, Gonzalez-Reche et al. identified both 1, N2-εG and N2, 3-εG in human urine 
(63). Recently the development of microflow rate LC system and nanospray interface 
improved the sensitivity of LC-MS/MS; the LOD of 1, N2-εdG could reach attomole-
level in this study and others (59). As shown in figure 2.6 and 2.9B, sub-femto mole LOD 
was provided by this nanoUPLC-MS/MS system with nanospray interface installed. 
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Background 1, N6-εdA and 1, N2-εdG can be consistently detected. Because of the 
instability of the glycosyl bond in N2, 3-εdG, the direct detection of this adduct by LC-
MS/MS was impeded (34, 49, 64).  
 
       M1G has been measured by MS, 32P-postlabeling or immunochemical techniques 
(25-29, 67). Each technique offers advantages and disadvantages based on a combination 
of sensitivity and specificity. 32P-Postlabeling was first employed for the detection and 
quantitation of M1G (17). Increased M1G was reported in the kidneys of Syrian hamster 
treated with estradiol, in white blood cells from women fed a diet high in sunflower oil 
and in normal breast tissues of women with breast cancer using this technique (68-70).  
Marnett’s laboratory employed GC-MS with electron capture negative chemical 
ionization detection for quantitation of M1G after immunoaffinity column purification 
and derivatization with pentafluorobenzyl bromide (17). The LOD of the assay was 
approximately 1 M1G per 108 nucleotides with 1mg of DNA. Using 500 ug MDA-treated 
ctDNA, Hakala evaluated the application of LC-ESIMS/MS for the measurement of M1G. 
Besides, several studies developed assays to measure M1dG indirectly and directly (26-29, 
67). Jeong et al. developed a novel method for analysis of M1dG by aldehyde reactive 
probe (ARP) labeling and LC-MS/MS with SPE purification (28). Both ring-open and 
ring-closed forms of M1dG were conjugated with a stable ARP group before detection, 
with an LOD of 2 M1G adducts/108 guanines.  Both LC-APCIMS/MS and LC-
ESIMS/MS were evaluated to measure the 5, 6-dihydro derivative of M1dG in urine after 
immunoaffinity and SPE column purification (26, 27). However, analysis of urine 
samples from control rats or rats treated with CCl4 indicated that the levels of M1dG were 
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below the LOD of LC-MS/MS system. To date, only one study reported the direct 
measurements of M1dG by accelerator mass spectrometry in rat urine (29). In our studies, 
because of the high sensitivity of nanoLC-MS/MS system, M1dG was detected directly 
after LC purification in control and chemically treated animal samples, as shown in figure 
2.9D, 2.10 and table 2.1. Considering the acid stability of M1dG (23, 24), 0.1% formic 
acid in water was used as phase A of LC purification and the reconstituting the solution 
after drying by speed vacuum. The background M1dG in control mice liver DNA was 4.9 
± 0.82 and 6.3 ± 1.8 adduct/108 dG, which was comparable to the background level in 
control rat liver determined by Jeong (28).  However, further comparison between these 
two assays is still necessary. 
 
       
32P-Postlabeling with LC purification was first developed for the detection of 
propano adducts (71). The whole process included four steps of LC purification, the 
postlabeling and enzymatic digestion steps with 300 µg DNA. Using this assay, Chung et 
al. successfully measured AcrdG and CrdG in the tissues of carcinogen-treated rodents 
and background lesions in DNA from humans and untreated rodents. Different patterns of 
adduct distribution were found in different organs of rodents (71, 72).  The average 
AcrdG and CrdG values were from 0.55 to 3.7 adduct/107 guanine, and from 0.09 to 3.97 
adduct/107 guanine in control rats respectively.  Because of incomplete separation of 
some AcrdG isomers from normal bases, only some of them were monitored in their 
studies. A similar assay was developed by Wacker et al. to measure 4-HNEdG (18). After 
enzymatic hydrolysis, the sample was subsequently reacted with [γ-32P] ATP to give the 
respective 3’-5’-bisphosphates, which were two-directionally separated on TLC and 
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quantitated by autoradiography. The concentration of adducts varied from not detected to 
158 adduct/109 normal nucleotides in control rats (18). However, 32P-postlabeling is labor 
intensive and low-throughput, requires handling large quantities of radioactivity and 
lacking information on chemical structure (73). These disadvantages indirectly promote 
the application of LC-ESIMS/MS techniques in the detection of these adducts (19-22), 
especially, with the advent of the low flow rate LC and electrospray interfaces of LC-
MS/MS, which provid outstanding sensitivity (low-femotomole to attomole detection 
limits) for the measurement of DNA adducts. By capillary LC-ESIMS/MS with SPE 
purification, AcrdG, CrdG and 4-HNEdG were successfully measured in 0.1~1.5mg 
DNA of human brain, liver and lung tissues (19-22). Although large quantity of DNA 
was used, it was still difficult to detect the endogenous CrdG in some samples (20). The 
complete separation of AcrdG and unmodified nucleosides was still a problem, although 
multiple enzyme systems or SPE columns were evaluated for its detection (19). Using up 
to 1mg DNA and long incubation time (overnight) for enzymatic digestion, Zhang et al. 
measured different isomers of AcrdG in human lung samples. However, whether long 
time or high temperature incubation could induce artifact formation was not investigated 
(19). Similar problems exist for the assay developed by Liu for measurement of 4-
HNEdG (21). In our studies, 2-hour incubation at 37˚C was applied instead of 100˚C (19) 
for a half hour or 37˚C for 24 hours (21). Besides, in order to get complete separation of 
AcrdG from unmodified nucleosides, 0.1% formic acid was added into 5mM ammonium 
formate aqueous solution as phase A. With slightly acid (pH = 3~4) mobile phase, all 
peaks of AcrdG isomers merged into a single peak and the baseline separation of AcrdG 
with unmodified nucleosides was achieved. Moreover, recovery studies found that similar 
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results were obtained when acid mobile phase was applied rather than neutral phase 
(5mM ammonium acetate in water) using pure AcrdG standards. Considering the 
lipophilicity of CrdG and 4-HNEdG, these two adducts were processed together using 
10mM ammonium acetate in water as phase A with a short LC gradient program. By 
nanoLC-MS/MS, the mean number of AcrdG, CrdG and 4-HNEdG adducts was 7.06 ± 
2.12/108 dG, 1.79 ± 0.34/109 dG and 2.70 ± 0.96/109 dG respectively in 0.45 ppm DBP 
treated trout liver, as shown in figure 2.10. No significant difference of these adducts was 
found between 0.45 ppm and 80 ppm DBP exposed samples, which can be explained by 
the possible limited LPO induced by DBP.  
 
        Although a variety of methods have been developed for the detection and 
quantitation of ROS-induced DNA adducts, most of them focused solely on measurement 
of one or two DNA adducts. Biochemical studies have validated the diverse pathways of 
formation, repair and mutagenic potential of different adducts, which supports the 
necessity of developing a battery assays to monitor multiple DNA adducts to better 
understand the roles of oxidative DNA adducts in risk assessment of chemical 
carcinogenesis. The initial exploration was made by Doerge et al. using LC-ESIMS/MS 
in 1998, which discussed the feasibility of LC-ESIMS/MS application for simultaneously 
measuring multiple LPO-induced adducts (65). Both nucleosides and nucleotides were 
tested on that system under full-scan and MRM modes, but no real samples were 
evaluated. Recently several studies were reported for simultaneously detecting multiple 
DNA adducts by LC-ESIMS/MS (34, 35, 49, 58, 59, 65, 66, 74-80). Offline LC (34, 49), 
immunoaffinity column (66), solid phase extraction purification (76, 77, 80), online 
 51
column-switching techniques (35, 65, 66, 75) and direct injection without any pre-
purification (74, 78, 79) were all evaluated for the detection of DNA adducts by LC-
ESIMS/MS.  One of the dominant problems for assay development of DNA adducts is 
efficient sample enrichment before adduct detection. With online column-switching 
technique, Doerge et al. developed an assay to detect 3, N4-εdC, 1, N6-εdA, M1dG and 8-
OHdG in 100 µg DNA simultaneously, but the interferences, which built up on the 
chromatographic columns, caused problems for adduct detections (66). Using similar 
techniques, Singh et al. developed an assay to simultaneously detect 8-OHdG and 8-
OHdA in DNA (75). It was found that the separation of 8-OHdA and dG, 8-OHdG and 
dG or dT was crucial for avoiding artifact formation and 8-OHdG or 8-OHdA detection 
(75). Considering the special technique requirement and potential contamination with 
online column purification, some investigators applied offline LC or SPE purification (35, 
49, 76, 77, 80).  Using neutral thermal or enzymatic hydrolysis of ethylene oxide (EO) 
treated DNA after offline LC purification, five different 2-hydroxyethyl-DNA adducts 
formed by ethylene oxide exposure were detected by LC-ESIMS/MS under MRM mode 
(76). With limits of detection in the range of 0.5 to 25 fmol for each individual adduct, 
this study illustrated the feasibility of this assay in the detection of 
endogenous/background EO-induced adducts in a variety of DNA samples. Nevertheless, 
artifactual peaks for N1-HEdA and O6-HEdG were observed in this study, which 
probably originated from cross-contamination with different fractions of the LC 
purification. Taghizadeh et al. successfully measured ROS-induced DNA adducts in 
rodents after collecting them individually on offline LC columns (49). Besides MRM, 
neutral loss monitor (NLM) was also applied to simultaneously measure multiple 
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endogenous DNA adducts (78-80). However, without isotopically labeled internal 
standards, the robustness and reliability of the assay is uncertain.  The 32P-postlabeling 
method was another technique evaluated for simultaneous quantification of exocyclic 
DNA adducts (15, 16).  After LC purification to remove unmodified nucleotides, DNA 
adducts were labeled and detected. But unlike immunoaffinity purification, residual 
levels of unmodified bases in the samples were hundreds of times higher than the target 
DNA adducts after purification by C18 or SPE columns, which have the capacity for 
removing 99.9% of unmodified bases from the samples. Without relevant chemical 
structure information, 32P-postlabeling needs to be further validated. In the present study, 
different enzymatic hydrolysis, LC purification and LC-MS/MS methods were evaluated 
for the detection of ROS-induced DNA adducts based on the special physiochemical 
properties of different DNA adducts. Considering the stability and sample purification of 
M1dG, 1, N2-εdG and AcrdG in acid mobile phase, these three adducts were combined to 
process together. The lipophilicity of CrdG and 4-HNEdG made it feasible to 
simultaneously purify them as well. Due to the artifact formation during sample 
processing for 8-OHdG detection and background interference for 1, N6-εdA detection, 
these two adducts were processed individually.  
 
       The major problem encountered in DNA adduct detection was the detection, 
structural identification and quantitation in animal and human samples where they are 
present in only minute amounts (1 modified base out of 106-1011 parent bases). Therefore, 
sensitive detection techniques become another key factor for successful assay 
development. Since the introduction MS in this area, several excellent reviews have been 
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written (11, 12, 81, 82, 37). Chiarelli et al. first comprehensively reviewed the application 
of mass spectrometry in the analysis of carcinogen-DNA adducts in the form of modified 
nucleosides in 1992 (81).  As a technique capable of elucidating the chemical structure of 
DNA adducts, mass spectrometry provided an incomparable advantage over the other 
techniques, such as providing specific chemical structure proof for validating the 
existence of DNA adducts in vivo.  However, because of the limited development of the 
sensitivity and hyphenated techniques for chromatography and mass spectrometers, very 
few adducts could be measured from in vivo sources (81, 82). GC-MS was the dominant 
MS technique for quantitative analysis of DNA adducts in biological samples after 
chemical derivatization during that period (81, 82). With the development of ESI 
interfaces and their successful application in LC-MS/MS, LC-ESIMS/MS became a 
dominant technique for the detection of DNA adducts since 1990’s (12, 13). Without a 
requirement for chemical derivatization and providing enough sensitivity for the 
detection of trace level DNA adducts, this technique has been applied in the measurement 
of various carcinogens induced DNA adducts, such as alkylating agents, aromatic 
carcinogens, arylamine carcinogens and even endogenous oxidative carcinogens (12, 13). 
Because the best performance of ESI interface was found at flow-rate around 0.5-5µl 
min-1, recent studies began to explore the application of micro- or nanobore LC columns 
in the detection DNA adducts combined with micro- or nanoESI interfaces (19-22, 59, 77, 
83-85). The advantages of low flow-rate LCMS systems over the traditional ones have 
been studied by several groups (85-87). Vanhoutte and his colleagues found that the mass 
sensitivity could be improved by a factor of 3300 by using nanoflow ES LC/MS, 
compared with conventional ES LC/MS system by analyzing a reaction mixture of 2´-
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deoxyguanosine 5´-monophosphate with bisphenol A diglycidyl ether (86). Hoes et al. 
reported that the absolute detection limit could be improved by a factor 10 using nano 
LC-MS than capillary LC-MS (87). Furthermore, several studies reported the application 
of capillary or nanoLC-ESIMS/MS in detection of various DNA adducts (59, 77, 83-85). 
Embrechts et al. reported that the LOD of equilenin-2´-deoxyguanosine adduct could 
reach 197 fg in MRM mode by nanoLC-ESIMS/MS (83). Additionally, Chen and his 
colleagues developed a sensitive assay for detection of crotonaldehyde and acrolein 
derived dG adducts by nanoLC-ESIMS/MS after SPE extraction of enzyme digestion 
hydrolytes, which was successfully applied to the samples from human placenta and 
leukocytes (77). All these studies supported the potential application of nanoLC-MS/MS 
in the detection of trace level DNA adducts in animal or human samples. 
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Figure 2.1 Mass spectrometry scheme for analysis of DNA adducts 
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Figure 2.2 1, N6-εdA level using the orginal method B (PD) and the optimized method B 
(OPD) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ns 
Student t-test, ns, no significant difference was found between these two groups, 
p>0.05, n=3 
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Figure 2.3 The optimization of enzyme digestion for the measurement of AcrdG and 
CrdG 
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Figure 2.4 The typical chromatograms for LC purification of CrdG, 4-HNEdG, AcrdG 
and 1, N2-εdG by UV detector 
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Figure 2.5 The chromatogram of LC purification for 1,N6-εdA and 8-OHdG by UV 
detector 
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Figure 2.6 Assay validations for 1, N6-εdA measurement 
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Figure 2.8 Instrument sensitivity comparisons for 1, N6-εdA detection (13C2)-VC 
exposed adult rat liver DNA (UPLC vs nano) 
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Figure 2.9A The typical chromatogram for ctDNA samples and calibration curve for 
8-OHdG by UPLC-MS/MS  
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DNA 
adduct 
8-OHdG 
(1/106dG) 
1, N6-
εdA 
(1/108 dA) 
1, N2-
εdG 
(1/108dG) 
M1dG 
(1/108 dG) 
AcrdG 
(1/107 dG) 
CrdG 
(1/109 dG) 
4-
HNEdG 
(1/109dG) 
n 22 31 10 5 9 9 5 
Median 4.6±1.7 
 
1.3±0.69 3.0±1.3 
 
4.7±2.2 1.2±0.4 
 
2.4±0.8 
 
9.0±2.2 
 
Table 2.1 ROS-induced DNA adducts in control liver DNA of adult female 
Sprague-Dawley rats (61 weeks old) 
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X02: control XPA-/- mice (olive oil 10 ml/kg); X07: XPA-/- mice exposed to CCl4 1600 mg/kg for 
13 days 
; 
2.10B. 1, N2-εdG, M1dG and AcrdG in XPA-/- C57BL/6J mice exposed to CCl4 
1600 mg/kg in olive oil by intraperitoneal injection for 13 days 
 
 
W02: control wild type mice; W07: wild type mice exposed to CCl4 
 
2.10A. 1, N2-εdG, M1dG and AcrdG in wild type C57BL/6J mice exposed to 
CCl4 (1600 mg/kg in olive oil) or olive oil (10 ml/kg) by intraperitoneal 
injection for 13 days 
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2.10D CrdG and HNEdG in the liver of Shasta strain rainbow trout exposed to 
dibenzo[a,l]pyrene (DBP) for 29 days 
2.10C 1, N2-εdG, M1dG and AcrdG in the liver of Shasta strain rainbow trout 
exposed to dibenzo[a,l]pyrene (DBP) for 29 days 
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CHAPTER III 
ENDOGENOUS AND EXOGENOUS 1, N6-ETHENO-2´-DEOXYADENOSINE IN 
WEANLING AND ADULT SPRAGUE-DAWLEY RATS EXPOSED TO VINYL 
CHLORIDE BY INHALATION 
 
A. INTRODUCTION 
 
        Vinyl chloride (VC) is a colorless organic gas used almost exclusively by the plastic 
industry to produce polyvinyl chloride and copolymers, which are ubiquitous materials in 
many consumer and industrial products. As one of the highest volume chemicals 
produced in the United States, the annual US production of VC increased from 
approximately 6 to 9 billion pounds in the late 1970s and to approximately 15 billion 
pounds in the mid 1990s (1). Among chemicals produced in the United States, VC ranked 
18th in production volume in 1995 (1). The reported production capacity for vinyl 
chloride was 17.6 billion pounds (8.0 billion kilograms) in 2000 (1). Besides 
anthropogenic sources, VC is also found in landfill leachates and in groundwater of sites 
polluted with halogenated hydrocarbons (2).  
 
        VC is a known human carcinogen with its primary target being hepatic endothelial 
cells, resulting in the induction of angiosarcoma (2, 3). As a multisite carcinogen, this 
chemical has also induced mammary gland carcinomas, nephroblastomas, lung adenomas, 
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and esthesioneuroblastomas in animal studies (3). VC is predominantly metabolized by 
cytochrome P450 2E1 to chloroetheylene oxide.  This reactive compound is a highly 
unstable epoxide that reacts with DNA and is thought to be the ultimate mutagen and 
carcinogen (4). VC is mutagenic in several systems (5), causing base-pair substitution 
mutations, which result from exocyclic DNA adducts (6, 7). Several mutations in key 
oncogenes and tumor suppressor genes have been reported in neoplasms of humans and 
animals exposed to VC. The mutations were consistent with the promutagenic properties 
of the VC-induced DNA adducts (8~14). Several DNA adducts are formed by VC, 
including the dominant adduct, 7-oxoethyl-guanine (7OEG), and the minor adducts, 1, 
N6-ethenodeoxyadenosine (1, N6-εdA), N2, 3-ethenoguanine (N2, 3-εG) and 3, N4-
ethenodeoxycytidine (15-18). These adducts can also be formed by lipid peroxidation 
induced by oxidative stress, which contributes to their endogenous presence (9-22). 
Several lipid peroxidation products play an important role in this process, including trans-
4-hydroxy-2-nonenal. 
 
          The connection between 1, N6-εA and the genotoxic effects of VC was first 
proposed by Barbin et al. in 1975 (15). He found that εA was formed in vitro by reaction 
of VC and mouse liver microsomes with adenosine. In the following years, several rodent 
studies (16~18) confirmed the importance of this adduct for VC genotoxic effects. The 
promutagenic properties and the repair pathways for this adduct were also widely studied 
in order to better evaluate the role of this DNA adduct on the mutagenic effects of VC in 
vivo (23~30). As one of the promutagenic etheno nucleosides, 1, N6-εdA can induce 
A→G transitions, as well as A→T and A→C tranversions.  Similar genetic changes were 
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found in p53 and H-ras genes in animal and human angiosarcoma DNA arising from VC 
exposure (7~9, 11). It was also discovered that more than one DNA repair enzyme was 
capable of removing such DNA lesions in different organisms (31~36). Alkyl-N-purine 
DNA glycosylase, was thought to be the primary repair pathway, however, it was 
reported recently that E. coli mismatch-specific uracil-DNA glycosylase and AlkB can 
also remove 1, N6-εdA with efficiency (34~36).   
          With the development of ultrasensitive detection methods of 1, N6-εdA, more 
molecular dosimetry studies have appeared (18, 37~42). Çiroussel et al. (37) determined 
1, N6-εdA concentrations in hepatic DNA of seven-day-old and 13-week-old BD VI rats 
exposed by inhalation to 500 ppm VC using HPLC and competitive radioimmunoassay. 
The limit of detection for this adduct was 3×10-8 1, N6-εdA/dA (± 15%, SD; n=27). It was 
observed that 1, N6-εdA adducts in liver were not significantly higher than those in lung 
and the brain. Guichard et al. (38) developed a 32P-postlabeling method to detect 1, N6-
εdA in VC exposed adult Sprague-Dawley rats. An exposure-dependent increase of 1, N6-
εdA was observed in liver DNA of these animals after 8 weeks of exposure. But this 
trend was not observed in lung, kidney nor circulating lymphocytes. Although 
accumulation of 1, N6-εdA in liver DNA of VC-exposed preweanling Sprague-Dawley 
rats was found (39), it was also observed that liver, the target organ of VC carcinogenesis, 
did not show higher amounts than other tissues in the exposed rodents (7). Although a 
slight decrease (from 2.1 to 1.4 mol/107 mol of parent base) of 1, N6-εdA was observed in 
liver DNA of preweanling rats 3 days after exposure to VC, the adduct remained ~1 
mol/107 mol of parent base over the following two weeks. Because of the existence of 
endogenous 1, N6-εdA, it is difficult to study exposure-related adducts.  
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        The primary focus of this chapter is on the relationship between endogenously 
formed 1, N6-εdA and exogenous 1, N6-εdA arising from inhalation exposure to VC, as 
well as accurately determining its rate of repair in rats exposed to (13C2)-VC. In order to 
evaluate the formation of endogenous and exogenous 1, N6-εdA in rodents after VC 
exposure, an inhalation rat study was designed that utilized exposure to stable isotope 
labeled (13C2)-VC, as shown in figure 3.1. In this study, a sensitive nanoUPLC-MS/MS 
assay was developed to detect both endogenous NA- and exogenous (13C2)-1, N6-εdA in 
the genomic DNA. Adult and weanling Sprague-Dawley rats were exposed to 1100 ppm 
(13C2)-VC for 1 week (6h/day, 5 days/week). The weanling animals were sacrificed 
immediately after the last exposure. The adults were sacrificed immediately, 2, 4, or 8 
weeks after exposure to evaluate the persistence of (13C2)-1, N6-εdA. Both age and organ 
specificity for 1, N6-εdA metabolism was evaluated in VC exposed rats. 
 
B. MATERIALS AND METHODS 
 
Materials 
 
        VC (99% chemical purity) was purchased from Supelco (Bellefonte, PA). (13C2)-VC 
(98% chemical purity; 99% isotopic purity) was obtained from Cambridge Isotope 
Laboratories (Andover, MA). Nucleic acid purification grade lysis buffer, protein 
precipitation solution and Proteinase K were purchased from Gentra Systems 
(Minneapolis, MN). Other chemical reagents including 1, N6-εdA standards were from 
Sigma-Aldrich Chemical Company (St Louis, MO) and used, without further purification. 
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HPLC grade water, methanol and other similar chemical solutions were purchased from 
ThermoFisher Scientific Company (Raleigh, NC). (15N5)-1, N6-εdA standard was 
synthesized and characterized as described by Ham et al. (32).  
 
Animal exposures 
 
         The detailed animal protocols were described in Mutlu’s studies (56). The animal 
exposure studies were conducted at the US Environmental Protection Agency, in 
Research Triangle Park, NC, and approved by their Institutional Animal Cares and Use 
Committee. The experimental design is shown in figure 3.1. For the adult studies, a total 
of 16 adult Sprague-Dawley male rats (10 weeks old) were exposed to 1100 ppm (13C2)-
VC. Adult rats were sacrificed immediately, 2, 4 and 8 weeks after 1-week (6 hours/day, 
5 days) (13C2)-VC exposure. An additional four adult Sprague-Dawley male rats were 
exposed to 1100 ppm unlabeled vinyl chloride for 1 day (6 hours/day) to test the initial 
exposure conditions. A total of 8 weanling rats Sprague-Dawley male (21 day old) also 
were exposed to 1100 ppm (13C2)-VC for one week (6 hours/day, 5 days) and sacrificed 
immediately after exposure. In addition, eight weanling rats were exposed to 1100 ppm 
unlabeled vinyl chloride for 1 day (6 hours/day). 
 
DNA isolation 
 
          Approximately 500 mg of tissue was thawed in 6 ml PBS solution, TEMPO, a 
radical scavenger was added to all solutions prior to homogenization using a Tehran 
homogenizer (Wheaton Instruments, Millville, NJ). After centrifugation at 1000g for 10 
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min, the nuclear pellet was resuspended in 5 ml cell lysis buffer. Proteinase K (50 U) was 
added to the samples and incubated overnight at 4˚C. Protein precipitation solution (2 ml) 
was added to remove the protein, and the supernatant was decanted to a new tube. 
Isopropanol (6 ml) was added to these samples, followed by gentle mixing by inversion. 
The DNA precipitated and was pelleted by centrifuging at 2000g for 5min at 4 ˚C. The 
DNA was washed with 70% ice cold ethanol. The DNA was reconstituted in 1ml ice cold 
PBS. An RNAase mixture containing RNAase T1 and RNAase A was added to these 
samples followed by incubation for 30 min at 37 ˚C. The DNA was rinsed with 100% 
ethanol, then 70% ethanol. Finally the DNA was resuspended in HPLC grade water and 
quantitated by UV spectrophotometry.  
 
1, N6-εdA measurement in isolated DNA 
 
         The procedure consisted of enzymatic hydrolysis, HPLC purification and LC-
MS/MS detection, as described in chapter 2. Briefly, the DNA in sodium acetate buffer 
(pH 5.6) underwent enzyme hydrolysis by the method of Pang et al. (40) with minor 
modification. After the addition of Nuclease P1 to 100 µg DNA and incubation at 37 ˚C 
for 1 h, the solution pH was adjusted with sodium acetate buffer (pH 8.1) and alkaline 
phosphatase (AP) and phosphodiesterase (PDE) was added with additional 1h incubation. 
Enzymes were removed by Microcon 10 filtration and the solvent was removed by 
vacuum evaporation. Samples were reconstituted in HPLC-grade water and stored at -80 
˚C until clean-up by C18 column on an Agilent 1200 Series analytical fraction collector 
system. For sample purification, all nucleosides were monitored at 264 nm. The relevant 
chromatography parameters were described in chapter 2. The column temperature was 
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kept as 30˚C. The quantitative analysis of 1, N6-εdA was performed using a 10 kpsi 
Nanoacquity Ultra Performance LC system (Waters, Milford, MA) coupled to a TSQ-
Quantum Ultra triple quad mass analyzer (ThermoFinnigan, San Jose, CA). A nanospray 
needle with 20 µm ID capillary ending and 10µm tip was obtained from New Objective 
(Woburn, MA). 1, N6-εdA was detected by multiple reaction monitoring (MRM) in the 
positive ESI mode, 276.0 to 160.0 for 1, N6-εdA and 281.0 to 165.0 for 15N5-1, N6-εdA. 
The capillary temperature was set as 285 ˚C. The spray voltage was 2000 V. CE was 16 
eV. Solvent A and B were 5mM ammonium formate in water and methanol respectively. 
 
Statistical analysis 
 
         Statistical analyses were performed using Microsoft Excel spreadsheet analysis 
tools and SAS Ver. 8.02 (Cary, NC) (19).  The amounts of 1, N6-εdA were reported as 
average and standard deviation (mean ± SD) for each animal group. The comparison 
between control and exposed group, adult and weanling rats was performed by using a 
student’s t test (two-sample unequal variances). Multiple comparisons of organ and time 
course differences in adduct levels were made by using one-way ANOVA in SAS. A 
significant difference was defined by p < 0.05 in both of these analyses. 
 
C. RESULTS 
 
1, N6-εdA adducts in liver DNA of VC exposed weanling and adult rats  
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         To determine the relationship between endogenous NA- and inhalation-derived 
exogenous (13C2)-1, N6-εdA in vivo, we monitored both adducts in the liver DNA of 
weanling rats exposed to 1100 ppm (13C2)-VC. After a 1-week (13C2)-VC exposure by 
inhalation, the weanling rats were sacrificed immediately. As described in figure 3.2, no 
significant change was observed for hepatic NA-1, N6-εdA between the control (1.13 ± 
0.22 1, N6-εdA per 108 unmodifed nucleosides) and exposed (1.42 ± 0.68 1, N6-εdA per 
108 unmodifed nucleosides) groups (p > 0.5). High amounts of (13C2)-1, N6-εdA (2.8 ± 
0.7 (13C2)-1, N6-εdA per 108 unmodified nucleosides) were found in the (13C2)-VC 
exposed liver DNA, which was twice the amount of the NA-1, N6-εdA level present in 
the same samples，as seen in figure 3.2 and 3.3. In addition, eight weanling rats were 
sacrificed after 1-day exposure to NA-VC with unexposed control animals. A two fold 
increase of NA-1, N6-εdA was observed in the exposed group (2.48 ± 0.39/108 
unmodified nucleosides), compared with the control (0.95 ± 0.23/108 unmodified 
nucleosides), as indicated in figure 3.4. Comparing the total amount of 1, N6-εdA (the 
sum of NA- and (13C2)-1, N6-εdA) in the liver DNA of weanling rats exposed to NA-VC 
for 1 day with (13C2)-VC for 1 week, it was found that more than a 4-fold increase was 
observed in the exposed group (4.21±1.17/108 unmodified nucleosides), compared to the 
control after 1-week (13C2)-VC exposure, as shown in figure 3.5, while only 2-fold 
increase was observed in the exposed group compared with the control after a 1-day NA-
VC exposure as indicated in figure 3.4.  
 
         Post-exposure studies were performed in adult rats in order to better evaluate the 
half-life of 1, N6-εdA. The typical chromatogram of 1, N6-εdA in the liver of adult rats 
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exposed to (13C2)-VC for 1 week without recovery was shown in figure 3.6. Four adult 
rats were sacrificed immediately, or 2, 4, or 8 weeks after 1-week 1100 ppm (13C2)-VC 
exposure by inhalation. (13C2)-1, N6-εdA (1.27 ± 0.15 (13C2)-1, N6-εdA /108 unmodified 
nucleosides) was detected in the liver of rats sacrificed immediately after exposure, while 
it was below the limit of detection in all post-exposure groups, indicating rapid repair of 
hepatic 1, N6-εdA after the exposure. No significant change was observed for the number 
of NA-1, N6-εdA lesions between the control and post-exposure groups, as shown in 
figure 3.7 (p > 0.05). Four adult rats were sacrificed after 1-day 1100 ppm NA-VC 
exposure with their control. The concentrations of NA-1, N6-εdA were 1.52 ± 0.36 × 10-8 
in the control and 3.72 ± 0.42 × 10-8 in the exposed livers, as seen in figure 3.8, 
demonstrating a two fold increase after 1-day of exposure. The increase in total 1, N6-εdA 
after 1-week (13C2)-VC exposure was 2.51 ± 0.12 vs 1.08 ± 0.17/108 unmodified 
nucleosides was similar to the increase observed following a 1-day NA-VC exposure in 
adult rats, as shown in figure 3.8 and 3.9. 
 
1, N6-εdA adducts in kidney and lung DNA of VC exposed weanling and adult rats 
  
         Significant changes were observed for NA-1, N6-εdA in the lung or kidney DNA of 
weanling rats after 1-week exposure to 1100 ppm (13C2)-VC exposure by inhalation, as 
indicated in figure 3.2. NA-1, N6-εdA concentrations in the control and exposed group 
were 1.76 ± 0.69 and 2.96 ± 0.64 adducts/108 unmodified nucleosides in the kidney DNA. 
NA-1, N6-εdA adducts were 1.43 ± 0.15 and 3.31 ± 0.85 adducts/108 unmodified 
nucleosides in the lung DNA of the control and exposed group respectively. The amounts 
of (13C2)-1, N6-εdA were 1.20 ± 0.33/108 unmodified nucleosides in the lung, and 0.81 ± 
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0.25/108 unmodified nucleosides in the kidney in weanling rats exposed to (13C2)-VC, as 
shown in figure 3.3. In addition, the total amounts of 1, N6-εdA in 1-week (13C2)-VC 
exposed lung and kidney DNA of weanling animals were increased 2 to 3-fold compared 
with the control group, which is similar to the increase of 1, N6-εdA in the lung and 
kidney DNA of 1-day 1100 ppm VC exposed weanling animals, as depicted in figure 3.4 
and 3.5. 
 
         One-week 1100 ppm (13C2)-VC exposure did not induce a significant change in the 
NA-1, N6-εdA adducts in the lung and kidney of adult rats, as depicted in figure 3.10. The 
concentrations of NA-1, N6-εdA were 0.97 ± 0.11×10-8 in the exposed and 0.77 ± 
0.29×10-8 in the lung of the control. The concentrations of NA-1, N6-εdA were 0.88 ± 
0.27×10-8 in the exposed and 0.70 ± 0.18×10-8 in the kidney of the control. (13C2)-1, N6-
εdA adducts in the lung were found to be the second highest (0.79 ± 0.06/108 unmodified 
nucleosides), followed by the kidney (0.50 ± 0.10/108 unmodified nucleosides) in the 
adult rats exposed to (13C2)-VC, as shown in figure 3.3. Moreover, significant increases 
of NA-1, N6-εdA adducts were found in the lung and kidney of adult rats after 1-day 1100 
ppm NA-VC exposure, as shown in figure 3.8. A 2-fold increase of total 1, N6-εdA was 
observed in the lung and kidney of adult animals after both 1-week (13C2)-VC and 1-day 
VC exposure, as depicted in figure 3.8 and 3.9. The total amounts of 1, N6-εdA were 
1.77±0.17 and 1.38±0.32 adducts/108 unmodified nucleosides in the lung and kidney 
DNA of adult animals after 1-week (13C2)-VC exposure without post. 
 
D. DISCUSSION 
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         The aim of this study was to measure the formation of both (13C2) and NA-1, N6-
εdA in adult and weanling rats after inhalation exposure to (13C2)-VC. Previously, such 
studies had only examined N2, 3-εG in rats, which forms 10 times more adducts than 1, 
N6-εdA in animals exposed to VC (41, 42). The quantification of 1, N6-εdA in animal 
tissues was first reported using competitive radioimmunoassay to measure 1, N6-εdA in 
the liver and lung DNA of preweanling rats exposed to VC (18). However, in these 
studies, 1, N6-εdA was not detected in unexposed control rats; it was highest in 
preweanling rats and just detectable in exposed adult rodents. This problem was resolved 
with the advent of a sensitive immunoaffinity purification/32P-postlabeling assay (43) that 
had a limit of detection of 5 1, N6-εdA per 1010 parent bases in DNA. Considering the 
small quantity of DNA required (usually around 10 µg), this assay has been widely 
applied in many dosimetry studies (18, 22, 37-39, 43-48). However, it also has some 
shortcomings. The accuracy of measurements does not use a true internal standard and no 
information about chemical structure of adducts is provided. Compared with 32P-
postlabeling methods, mass spectrometry is a powerful technique because it can 
distinguish different carcinogen-DNA adducts, provide chemical structure information 
and employ an authentic internal standard. Although LC-MS has been applied in 1, N6-
εdA detection since 1999 by Doerge (49), it has not been widely used for quantitative 
analysis of trace endogenous DNA adducts because it is generally less sensitive than 32P-
postlabeling. However, through recent ESI developments such as microelectrospray and 
nanospray devices coupled with highly efficient separation techniques and miniaturized 
chromatographic columns with less than 2 µm particle size, nanoUPLC-nanoESI/MS/MS 
systems can provide more than 20 times better sensitivity compared to conventional LC-
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MS/MS systems, as shown in chapter 2. Besides improved sensitivity, this system also 
brings advantages in terms of reduced solvent and sample consumption (50).  
 
         Using this new assay, the repair efficiency of (13C2)-1, N6-εdA was investigated in 
DNA from adult rats exposed to 1100 ppm VC for 1 week and sacrificed immediately, 2, 
4 or 8 weeks post-exposure. Since (13C2)-1, N6-εdA was only detected in the liver, lung 
and kidney from the group sacrificed immediately after exposure, it was rapidly repaired 
in these organs. It is assumed that (13C2)- and NA-1, N6-εdA are repaired in the same 
manner. While (13C2)-1, N6-εdA was repaired so that none could be detected 2, 4 or 8 
weeks after exposure, but the number of NA-1, N6-εdA was constant in liver over time, as 
shown in figure 3.7. Its presence was due to continuous endogenous formation by lipid 
peroxidation. Several studies reported rapid repair of 1, N6-εdA in mice. Barbin (31) 
studied the persistence of 1, N6-εdA in liver and lung DNA from 6-week-old male and 
female C57Bl/6J mice after five daily i.p. injections of 250 nmol/g of vinyl carbamate. 
These animals were sacrificed at different time intervals (from 6 h to 96 h) after the final 
dose. The estimated half-life of 1, N6-εdA was 21 ± 3 h in hepatic DNA and 20 ± 3 h in 
lung DNA of both male and females. Ham et al. (32) found the half-life of 1, N6-εdA 
from DNA in liver and lung of male mice to be 17 h and 28 h respectively and similar 
results were obtained for female mice. Both Barbin and Ham observed that even in alkyl-
N-purine-DNA glycosylase (ANPG, or N-methylpurine-DNA glycosylase, MPG)/Aag 
knock-out mice, the amounts of 1, N6-εdA decreased after vinyl carbamate exposure and 
postulated that an additional repair pathway was involved. These results were recently 
supported by the observations that direct reversal repair is another pathway for repairing 
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1, N6-εdA (34-36). Moreover, the repair of 1, N6-εdA was also suggested by detecting εA 
in the urine of adult male Fischer 344 rats following i.v. administration of 8.5 mg 
chloroethylene oxide/kg body weight (51). The excretion of εA increased greatly in the 
first 24 h after exposure and plateaued after that. All these studies showed that 1, N6-εdA 
is rapidly repaired in liver and lung of adult rodents, with no differences between gender 
and species. Although several studies reported the persistence of 1, N6-εdA or εA (31, 38, 
39, 41), these studies could not differentiate between adducts from VC exposure and 
endogenous formation through lipid peroxidation. In the present study, it is clear that 
continuous endogenous formation was the key factor responsible for the apparent 
persistence of this rapidly repaired adduct.  
 
         The accumulation of total 1, N6-εdA was analyzed by comparing the amounts of 1, 
N6-εdA in liver DNA of adult rats after a 1-day 1100 ppm VC exposure with the data 
from rats sacrificed immediately after 1-week of (13C2)-VC exposure. It was found that in 
both exposure scenarios total 1, N6-εdA doubled, as shown in figure 3.8 and 3.9. Thus, 
the only accumulation identified was associated with the last day of exposure. Significant 
accumulation was not demonstrable in the kidney or lung of adult rats. Guichard et al. (38) 
reported the accumulation of 1, N6-εdA in the liver of adult Sprague-Dawley rats exposed 
to 500 ppm VC for 1, 2, 4 or 8 weeks, but not in the lung and kidney. Using a simple 
linear regression model to fit the data of post-exposure time and 1, N6-εdA level, the 
estimated accumulated rate of 1, N6-εdA in the liver DNA of adult rats expressed as the 
slope of this curve was 0.682 × 10-8/week. However, the methods employed could not 
differentiate between exogenous and endogenous 1, N6-εdA. Other possibilities that must 
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be considered include saturation or increased expression of one or more DNA repair 
pathways for 1, N6-εdA. A study by Holt et al. (52) evaluated the effect of vinyl fluoride 
exposure, which forms the same DNA adducts as VC, on gene expression of the N-
methylpurine-DNA glycosylase (MPG), a repair enzyme for etheno adducts. Holt et al. 
found that the expression of MPG was similarly induced following either 25 or 2500 ppm 
vinyl fluoride in the liver of adult Sprague-Dawley rats (52). The nontarget tissues, 
kidney and lung, did not exhibit induction of MPG expression after VF exposure, as 
similar amounts of MPG were observed in both tissues in control and exposed animals. 
Similar gene expression studies would be needed to determine if the differences in 
exogenous 1, N6-εdA adducts among different organs or between weanling and adult 
animals following exposure to (13C2)-VC could be the result of the induction of repair 
enzymes, Thus, a dynamic balance between 1, N6-εdA formation and repair pathways 
may have age and/or organ related differences that could affect susceptibility.  
 
         Although previous studies (7) found that the number of etheno adducts (1, N6-εdA 
and 3, N4-εdC) in the liver of adult rats, the major target organ of VC, were not higher 
than other tissues after VC exposure, VC-induced (13C2)-1, N6-εdA did show the greatest 
number of adducts in the liver, compared with lung and kidney in both weanling and 
adult rats exposed to (13C2)-VC. The mean number of (13C2)-1, N6-εdA across these 
organs was liver>lung>kidney, as shown in figure 3.3. Multiple comparisons indicated 
significant differences for (13C2)-1, N6-εdA between liver and kidney (p < 0.05) in the 
adult rats, but not between liver and lung. Significant differences for (13C2)-1, N6-εdA 
were also detected between liver and lung, liver and kidney, but not kidney and lung in 
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weanling rats. Relatively homogeneous distributions of 1, N6-εdA were observed among 
tissues in adult rats in studies by Barbin (7) following exposure to vinyl chloride. As 
shown in figure 3.4 and 3.8, without distinguishing endogenous and exogenous 1, N6-εdA, 
similar amounts of 1, N6-εdA were observed in liver, lung and kidney from both 1-day 
1100 ppm VC exposed adult and weanling rats in this study. Furthermore, similar total 
amounts of 1, N6-εdA (NA- 1, N6-εdA and (13C2)-1, N6-εdA) were found in the liver, lung 
and kidney of weanling animals exposed to (13C2)-VC, as shown in figure 3.5..  
 
         Previous studies showed that the concentrations of 1, N6-εdA and N2, 3-εG in 
weanling animals were higher than in adult rats exposed to VC (37, 53). Çiroussel et al. 
(37) measured 1, N6-εdA in DNA of several organs of seven-day-old (group I) and 13-
week-old BD VI rats (group II) after 2-weeks exposure to 500 ppm VC. It was found that 
the amounts of 1, N6-εdA in liver DNA of group II was six times lower than group I. 
Similar results were found for N2, 3-εG in the studies of Morinello et al. (53). The 
concentrations of N2, 3-εG in liver DNA of weanling rats were 2-3 fold greater than those 
of the adults after VC exposure. In the present studies, (13C2)-1, N6-εdA in liver DNA of 
weanling rats was two times higher than those of the adults exposed to 1100 ppm (13C2)-
VC for 1 week. In addition to liver, kidney and lung also showed higher amounts of 
(13C2)-1, N6-εdA in the weanling rats, as shown in figure 3.3. Although the number of 
(12C2)-εdA adducts did not increase in liver, lung and kidney of adult rats after 1-week 
exposure to 1100 ppm (13C2)-VC, (12C2)-εdA adducts did increase in the lung and kidney 
DNA of weanling rats. This could be the result of increased lipid-peroxidation in these 
tissues. The high VC adduct concentrations in young animals, coupled with increased cell 
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proliferation due to a steep growth rate, are key events in their greater susceptibility to 
VC-induced hepatic angiosarcoma and hepatocellular carcinoma, compared to adult 
animals. Classical long-term experimental carcinogenicity studies have shown that the 
susceptibility of hepatocytes to the carcinogenic effect of VC is age-dependent (54).  
Maltoni’s study demonstrated that newborn rats, in contrast to adult animals, responded 
to VC with the development of hepatocellular carcinomas, and hemangiosarcomas (54). 
Drew et al. (55) studied age-related susceptibility to VC in rats, golden hamsters and 
mice. Rats held for 6 months before exposure developed VC-related neoplasm, while rats 
held 12 months before the start of exposure failed to show a significantly increased 
incidence of these neoplasm. The highest incidence of malignant neoplasm occurred in 
hamsters exposed for the first 12 months, whereas beginning the exposure after 12 
months of age did not cause neoplasm. In Swiss CD-1 and B6C3F1 mice, VC exposure 
during the first 6 months of the experiment induced a high incidence of 
hemangiosarcomas. All these studies clearly indicated that VC exposure starting at early 
stage in the life was most effective. The increase in metabolism of VC resulting in 
increased numbers of VC adducts, coupled with greater cell proliferation provides the 
mechanistic basis for this increased risk for VC-induced cancer. 
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Figure 3.1 The experimental design 
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Figure 3.2 NA-1, N6-εdA amounts in (13C2)-VC exposed and control weanling rats 
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one-way ANOVA 
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p values (two-sample t-test) for comparison between weanling and adult groups:   *,  p<0.05; ns, 
no significant difference, p>0.05. For adult, n=4; for weanling, n=6~8. Multiple comparisons of 
organ were made by using one-way ANOVA. **, p<0.05  between adult liver and kidney; ***, 
p<0.05 between weanling liver and lung; ****, p<0.05 between weanling liver and kidney. 
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Figure 3.4 NA-1, N6-εdA amounts in the NA-VC exposed and control 
weanling rats 
p values (two-sample t-test) for comparison between treated and control groups:   *,  p<0.05; ns, no 
significant difference, p>0.05, n=6~8. Multiple comparisons of organ were made by using one-way 
ANOVA 
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Figure 3.6 Typical chromatogram for 1, N6-εdA detection in the liver of (13C2)-VC 
treated adult rats. 
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Figure 3.7 NA-1, N6-εdA amounts in the control and (13C2)-VC exposed adult 
liver DNA with different recovery time 
p values (two-sample t-test) for comparison between VC-exposed and control groups:   ns, no significant 
difference, p>0.05, n=3~4. Multiple comparisons of organ were made by using one-way ANOVA 
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p values (two-sample t-test) for comparison between treated and control groups:   *,  p<0.05; ns, 
no significant difference, p>0.05, n=4. Multiple comparisons of organ were made by using one-
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Figure 3.9 Total amount of 1, N6-εdA in adult rats after 1-week exposure of 
(13C2)-VC by inhalation 
p values (two-sample t-test) for comparison between VC-exposed and control adult animals: *,  
p<0.05; ns, no significant difference, p>0.05, n=3~4. Multiple comparisons of organ were 
made by using one-way ANOVA 
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p values (two-sample t-test) for comparison between treated and control groups:   *,  p<0.05; ns, 
no significant difference, p>0.05, n=3~4. Multiple comparisons of organ were made by using 
one-way ANOVA 
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CHAPTER IV 
SPECTRUM OF DNA LESIONS INDUCED BY REACTIVE OXYGEN SPECIES IN 
SPRAGUE-DAWLEY RATS CHRONICALLY EXPOSED TO 2, 3, 7, 8-
TETRACHLORODIBENZO-p-DIOXIN AFTER DIETHYLNITROSAMINE 
INITIATION 
 
A. INTRODUCTION 
 
         2, 3, 7, 8-Tetrachlorodibenzo-p-dioxin (TCDD), commonly known as dioxin, is one 
of the most toxic environmentally persistent organic pollutants (1). Although without 
commercial use, it can be formed from various sources, such as the manufacture or 
degradation of other chlorophenols and their derivatives, municipal incinerators, sewage 
sludge and discharge from paper mills (1). Because of its lipophilicity, stability, and 
resistance to biodegradation, TCDD can accumulate in human adipose tissues and cause 
chronic lifetime exposure which may evoke long-term toxicity. Although with limited 
data on epidimeology studies, TCDD was still classified as a group 1 carcinogen by the 
International Agency for Research on Cancer (IARC) based on adequate evidence of its 
multisite carcinogenicity in rodents (2-3). The key event that is thought to drive these 
biological effects is TCDD binding to a receptor protein, aryl hydrocarbon receptor 
(AhR). The ligand-receptor complex subsequently binds to the AhR nuclear translocator 
(ARNT) in the nucleus, which binds to DNA, triggering the expression of a variety of 
genes, especially CYP450 (4). The up-regulation of these enzymes may greatly speed up
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the oxidative transformation of endogenous and exogenous compounds in the body and 
induce reactive oxygen species (ROS). Although considered a non-genotoxic compound, 
TCDD may cause continuous indirect oxidative DNA damage by inducing the 
accumulation and persistence of ROS through up-regulation of CYP450.  
 
         ROS can react with DNA directly and form various DNA lesions. One of the most 
studied one is 7, 8-dihydro-8-oxo-2′-deoxyguanosine (8-OHdG). It is formed in relatively 
high amounts in vivo with background amounts around 1/106 guanine (5). ROS can also 
abstract a hydrogen atom from polyunsaturated fatty acids to initiate lipid peroxidation 
and produce various unsaturated aldehydes, such as malondialdehyde (MDA), 4-HNE, 
crotonaldehyde, and acrolein. These compounds can react with DNA and form exocyclic 
adducts: etheno adducts and propano adducts (6). The dominant etheno adducts are 1, N6-
etheno-2’-deoxyadenosine (1, N6-εdA), 3, N4-etheno-2’-deoxycytidine (3, N4-εdC), 1, N2-
etheno-2’-deoxyguanosine (1, N2-εdG), and N2, 3-ethenoguanine (N2, 3-εG). The primary 
propano-derived DNA adducts are 1, N2-propano-2’-deoxyguanosines generated from 
acrolein (AcrdG), crotonaldehyde (CrdG) and 4-HNE (4-HNEdG). The major MDA-
induced DNA adduct is 3-(2-deoxy-β-D-erythropentofuranosyl) pyrimido (1,2-α)purin-
10(3H)-one (M1dG). The accumulation of ROS-induced DNA adducts is thought to be a 
potential hazard in vivo because of their connection with mutations (7-11). Site-directed 
mutagenicity studies found that most ROS-induced adducts can cause specific transition 
and/or transversion point mutations in bacteria and/or mammalian cells. In addition, the 
persistent increase of 1, N6-εdA, 3, N4-εdC and 8-OHdG has been found in various 
premalignant target organs affected by disease, such as acute leukemia, colorectal cancer 
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and hepatic cancer (12-15). These studies provide strong support for the hypothesis that 
oxidative DNA damage plays an important role in carcinogenesis. 
 
         Oxidative stress has been used as a marker for the toxicity of TCDD and its 
congeners since the beginning of 1980s (16). Both in vitro and in vivo studies indicated 
increased production of ROS after TCDD exposure, which was regarded as the result of 
TCDD-mediated activation of AhR and a shift in the cellular redox balance (17). 
Therefore, it was widely hypothesized that the toxicity induced by TCDD in rodents was 
at least partly explained by the contribution of oxidative stress, an observation reported in 
many studies (18-24). Although most of these studies were acute or subchronic studies, 
several relevant chronic studies were also reported. All of them focused on the oxidative 
stress in the liver of female Sprague-Dawley rats, which is a sensitive strain with high 
hepatic tumor incidence after TCDD exposure. Tritscher et al. (18) first reported 
increased 8-OHdG in livers of TCDD treated intact, but not ovariectomized female rats 
after diethylnitrosamine (DEN) initiation. Wyde et al. (19) further found the induction of 
hepatic 8-OHdG by TCDD in female rats after DEN initiation and demonstrated that it 
was female-specific, estrogen-dependant and was a chronic effect. Recently, Hassoun et 
al. (20) observed increased production of superoxide anion, lipid peroxidaiton and DNA 
single-strand breaks in hepatic tissues of rats after 30 weeks exposure to TCDD. All of 
these studies supported the importance of oxidative DNA damage in carcinogenesis of 
TCDD.  
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         The aim of the current study was to further study the oxidative DNA damage 
spectrum induced in the liver of Sprague-Dawley rats chronically exposed to TCDD after 
DEN initiation. Previous two-stage liver tumor promotion studies on TCDD observed 
significant increased 8-OHdG in TCDD exposed hepatic tissues of female rats (18, 19). 
But considering the distinct formation, repair pathways and promutagenicity of different 
ROS-induced DNA adducts, it’s valuable to measure other adducts. Besides, the 
reliability of 8-OHdG as a good biomarker of ROS has been offset by artifactual 
formation during sample processing (5, 25), which has impeded maximal application of 
this adduct in understanding and assessing the risk of carcinogenesis. In order to expand 
our knowledge on these issues, a series of ROS-induced DNA adducts were measured in 
the samples provided by Wyde et al. (19). The comprehensive DNA adduct profile will 
include 8-OHdG, 1, N6-εdA, CrdG, and AcrdG. These data will help us better understand 
the role of ROS-induced DNA damage in hepatic carcinogenesis of TCDD in this two-
stage carcinogenesis model.  
 
B. MATERIALS AND METHODS 
 
Materials  
         Nucleic acid purification grade lysis buffer, protein precipitation solution and 
Proteinase K were purchased from Gentra Systems (Minneapolis, MN). Other chemical 
reagents including 1, N6-εdA and 8-OHdG standards were from Sigma-Aldrich Chemical 
Company (St Louis, MO). HPLC grade water, methanol, other similar chemical solutions 
and 2,2,6,6-tetramethylpiperidinyl-1-oxy (TEMPO) were purchased from ThermoFisher 
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Scientific Company (Raleigh, NC). 15N5-1, N6-εdA standard was synthesized and 
characterized as described by Ham et al. (26). 15N5-8-OHdG and 15N5-2΄-deoxyguanosine 
were purchased from Cambridge Isotope Laboratories (Andover, MA, USA). The 
standards for AcrdG and CrdG and their 15N5 labeled internal standards were synthesized 
according to previous studies (27, 28). The materials in animal exposure studies were 
described in detail in Wyde’s reports (19). 
 
Animal exposure 
         The animal study was performed in 1998 and described previously in detail by 
Wyde et al. (29, 30). All animals were housed in cages with control temperature (70 ± 
0.5°F), humidity (50 ± 5%) and lightling (12-h light/12-h dark) and received NIH-31 diet 
(Zeigler Brothers Inc., Gardner, PA) and water ad libitum. The whole animal design is 
shown in figure 4.1. Four different exposure scenarios (A, B, C, and D) were applied for 
both male and female Sprague-Dawley rats provided by Charles River Labs (Raleigh, 
NC). Female rats were ovariectomized or sham operated (intact) at the age of 8 weeks 
before any treatment. All animals were initiated by single dose of 175 mg DEN/kg of 
body weight (BW) at 10-weeks-of-age. Intact female rats were implanted with placebo 
pellets and treated with olive oil (scenario A), or exposed to 700 ng/kg TCDD weekly for 
30 weeks (scenario C). OVX female rats were either implanted with 0.18 mg, 1.7 mg E2, 
or placebo. At 12 weeks, some OVX rats were treated with a weekly dose of corn oil 
(scenario A), or 700 ng/kg/week TCDD for 30 weeks without E2 supplement (scenario C). 
Some OVX rats were treated with a weekly dose of corn oil (scenario B), or 700 
ng/kg/week TCDD for 30 weeks with 0.18 mg or 1.7 mg E2 supplement (scenario D).  
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The dose of TCDD (700 ng/kg/week) was equivalent to a daily 100 ng/kg/day, which 
induced liver tumors in female rats in chronic studies (31). 
 
         All intact male rats were initiated by a single dose of 175 mg DEN/kg of body 
weight at 10-weeks-of-age. One week after initiation, one group was implanted with 90-
day release pellets containing placebo and treated with olive oil for 30 weeks (scenario 
A); one group was implanted with pellets containing 0.18 mg of E2 and treated by olive 
oil for 30 weeks (scenario B); one group was exposed weekly to 700 ng/kg TCDD for 30 
weeks with the placebo supplement (scenario C); the last group was exposed to the same 
amount of TCDD for 30 weeks with 0.18 mg E2 as supplement (scenario D). New pellets 
containing placebo or E2 were implanted after 90 days in these animals.  All male and 
female animals were sacrificed by asphyxiation with CO2 at the end of exposure. Liver 
tissues were removed, frozen in liquid nitrogen and store at -80 ˚C before DNA isolation.   
 
DNA isolation 
         About 500 mg of tissues were homogenized with a Tehran homogenizer (Wheaton 
Instruments, Millville, NJ) in PBS solution and centrifuged at 1000 g for 10 min. The 
formed pellet was suspended in lysis buffer. Protein was removed from the sample by 
adding Proteinase K (400 U/ml) in the sample, rotating overnight in 4 ˚C cold room and 
precipitated by Protein precipitation solution. On the second day, the sample was 
precipitated at room temperature by isopropanol, rinsed by 70% ice cold ethanol aqueous 
solution and reconditioned in cold PBS solution. Then RNAase mixture, containing 
RNAase T1 and RNAase A, was added to the sample and incubated for 30 min at 37 ˚C. 
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Finally, the sample was rinsed with 100% ethanol and its 70% aqueous solution, 
resuspended in HPLC grade water and stored at -80 ˚C. The concentration and purity of 
DNA was measured by Biomate 5 (Thermo Spectronic, NY, USA). TEMPO (20 mM) 
was present in the samples during the whole DNA isolation process to inhibit formation 
of free radical species. 
 
Enzymatic hydrolysis and HPLC purification 
          The whole process has been described in detail in chapter 2. Briefly, slightly 
different enzymatic hydrolysis was applied for different adducts depending on their 
physiochemical properties. The digestion method for 1, N6-εdA was modified based on 
the studies of Pang et al. (25) and the optimized method C was applied with 2 h 
incubation at 37 ˚C. For 8-OHdG detection, the same enzymatic digestion process as 1, 
N6-εdA was applied to digest 50 µg DNA. TEMPO (20mM final concentration in the 
sample) was present through the whole sample processing. Since some studies mentioned 
that DNase I was necessary for bulky DNA adduct digestion (32), 50 U DNase I was 
added with nuclease P1 during the enzymatic digestion for AcrdG and CrdG detection. 
After enzymatic hydrolysis, proteins were removed by micron-10 filter followed by 
HPLC purification of the sample. Three different LC methods were applied for 1, N6-εdA, 
8-OHdG and AcrdG or CrdG respectively, as described in chapter 2. The column 
temperature was kept as 30 ˚C for all sample purification. An Atlantis T3 (5 µm, 4.5×150 
mm) was utilized.  
 
LC-MS/MS detection 
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         Two different LC-MS/MS systems were used to analyze these adducts. 8-OHdG 
was analyzed by a UPLC-MS/MS system consisting of Aquity UPLC system (Waters, 
Milford, MA) and TSQ-Quantum ultra triple quad mass analyzer (ThermoFinnigan, San 
Jose, CA). Sample separation was performed on T3 HSS column (1.7 µ, 2.1×100 mm) at 
a flow rate of 200 µl/min. Mobile phases consisted of 0.1% acetic acid in water as A and 
0.1% acetic acid in methanol as B.  The quantitative analysis of 1, N6-εdA, AcrdG and 
CrdG was performed on 10 kpsi nanoacquity Ultra Performance LC system (Waters, 
Milford, MA) coupled to a TSQ-Quantum ultra triple quad mass analyzer 
(ThermoFinnigan, San Jose, CA). A nanoacquity symmetry trap column (180 µm × 20 
mm, 5 µm) was connected with a nanoUPLC BEH C18 analytical column (1.0 mm × 100 
mm, 1.7 µm) through a control valve.  Mobile phase A was 5 mM ammonium formate for 
1, N6-εdA detection, and 0.1% formic acid in water for AcrdG and CrdG detection 
respectively. Phase B was acetonitrile with 0.1% formic acid for the detection of allthree 
adducts. The detailed LC gradient program and MS parameters were as described in 
chapter 2. 
 
Statistical analysis 
         Statistical analyses were performed using R (version 2.11). Since the variances in 
DNA adduct data were not homogeneous and samples sizes were limited for certain 
groups, nonparametric Wilcox Rank Sum test was used to assess the difference between 
control and exposed groups. Multiple pair-wise comparisons were corrected calculating 
permutation p-values using 100,000 permutations. p-value was considered significant if 
they were less than 0.05. Data from the present study were reported as mean ± SD to 
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allow a direct comparison with other previously published relevant studies in which mean 
values were reported. 
          
C. RESULTS 
 
         Following 30 weeks exposure to TCDD, significant increases of 8-OHdG were 
observed in the liver of intact female rats after DEN initiation compared with the control 
group (19.5 ± 10.7 adduct/106dG vs 6.4 ± 2.13 adduct/106 dG, p = 0.016), as shown in 
figure 4.2. With E2 supplement, 8-OHdG level was enhanced in the liver of OVX female 
rats after 30-week exposure of TCDD with DEN as initiator. However, a significant 
increase was only observed in the exposed group with 1.7 mg E2 supplement (p = 0.016), 
not with 0.18 mg E2 (p = 0.29), by comparing with their respective control groups. 
Similar amounts of 8-OHdG were detected in the TCDD treated OVX group with 1.7 mg 
E2 (22.3 ± 13.4 adduct/106 dG) to the intact TCDD treated female rats. Without the E2 
supplement, no significant formation of 8-OHdG was observed in the OVX rats after 30 
weeks exposure of TCDD (p = 0.095). The number of 8-OHdG adducts in the control and 
exposed groups was 2.9 ± 0.24 adduct/106 dG and 3.2 ± 0.5 adduct/106 dG respectively. 
Ovariectomy and E2 supplement showed a slight effect on background numbers of 8-
OHdG in control animals. Lower mean levels of 8-OHdG were found in the control OVX 
group than the intact one, but the difference was not significant (p = 0.095). Slightly 
higher background 8-OHdG was detected in the OVX rats with E2 than the 
nonsupplemented OVX rats, as shown in figure 4.2. 
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         1, N6-εdA, AcrdG and CrdG were also measured in the same samples and the 
results are shown in figure 4.3A and B. Following 30 weeks of TCDD treatment, 1, N6- 
εdA was significantly increased in intact female rats and OVX rats with 1.7 mg E2 
supplement. The number of 1, N6-εdA in intact TCDD treated and control group was 
20.33 ± 8.9 and 5.76 ± 2.4/108 dA, respectively (p = 0.0095). The number of 1, N6-εdA in 
OVX TCDD treated and control groups with 1.7 mg E2 supplement was 9.1 ± 2.1 and 3.9 
± 1.7/108 dA, respectively (p = 0.001). Although an increase of AcrdG and CrdG was 
found in intact female rats and OVX rats with 1.7 mg E2 supplement after TCDD 
treatment compared with their corresponding control group, neither of them was 
statistically significant compared with the control, as shown in figure 4.3B. The number 
of AcrdG adducts in intact TCDD treated and control female groups was 21.3 ± 6.2 and 
6.8 ± 2.2/107 dG, respectively; and the difference between them was marginally 
significant (p = 0.056). The number of AcrdG in OVX TCDD treated and control female 
group with 1.7mg E2 supplement were 9.1 ± 3.9 and 4.5 ± 1.0/107 dG, respectively (p = 
0.1). Higher amounts of AcrdG and CrdG were found in TCDD treated intact female rats 
than the OVX female rats with E2 supplement, as shown in figure 4.3B. In addition, 
slightly lower background numbers of 1, N6-εdA, AcrdG and CrdG were found in OVX 
control rats than the intact female control rats, although no significant difference between 
them was present. With E2 as supplement, the background amounts of 1, N6-εdA, AcrdG 
and CrdG in OVX control female rats were similar to the control without E2. 
 
         8-OHdG and 1, N6-εdA were measured in TCDD treated male rats after DEN 
initiation with and without 0.18 mg E2 supplement, as shown in figure 4.4. Following 30 
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weeks of treatment, increases of 8-OHdG were observed in male rats, with or without the 
E2 supplement. Without E2 supplement, the amount of 8-OHdG was 4.72 ± 0.6 and 4.2 ± 
0.4/106 dG in the TCDD treated and control male group, respectively. With the E2 
supplement, higher amounts of 8-OHdG were detected in the control and TCDD-treated 
male group. The background of 8-OHdG in hepatic DNA of male rats was slightly lower 
than in the intact female, as shown in figure 4.2 and 4.4. Although TCDD induced an 
increase of 8-OHdG in male rats, it was not statistically significantly. Besides, no 
significant difference of 1, N6-εdA was found in the livers of these animals. The amounts 
of 1, N6-εdA in TCDD treated and control male groups without E2 were 3.26 ± 0.96 and 
3.01 ± 1.12 /108 dA, respectively. In the 0.18 mg E2 supplemented group, the values of 
1,N6-εdA were 3.11 ± 0.45 and 3.21 ± 0.63 adduct /108 dA for the control and treated 
group, respectively. 
         
 D. DISCUSSION 
 
         Oxidative DNA damage has been identified as a potential important contributor in a 
myriad of diseases, especially cancer (12-15). Various oxidative DNA lesions have been 
investigated for their role in carcinogenesis (12, 13). Among them, 8-OHdG and 1, N6-
εdA were the most widely studied oxidative DNA adducts. Site-directed mutagenicity 
studies found that they can induce specific point mutations in bacteria and/or mammalian 
cells. The presence of 8-OHdG during DNA replication can cause G to T transversions 
(13). The presence of 1, N6-εdA can cause A to G transitions, and A to T, A to C 
transversions (6-8). Although reports concerning the biological significance of AcrdG 
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and CrdG are limited, both have been found to be capable of inducing G to T 
transversions in COS-7 system as the dominant mutation (11). Because of the 
controversy over the significance of 8-OHdG as a good biomarker for oxidative DNA 
damage, 1,N6-εdA, AcrdG and CrdG were also measured in this study to explore the 
breadth of oxidative DNA damage in the hepatic toxicity of female Sprague-Dawley rats 
induced by TCDD in the two stage carcinogenesis study.  
 
         Using LC-ECD and direct injection after enzyme digestion, Wyde et al, (30) 
measured 8-OHdG in the liver of intact and OVX female rats exposed to TCDD for 30 
weeks after DEN initiation. In his study, 18-fold higher 8-OHdG was found in the TCDD 
treated intact female group than their control. The mean levels of 8-OHdG in these 
groups were 47.10 adduct/106 dG and 2.6 adduct/106 dG, respectively. In 0.18 mg E2 
supplemented OVX female rats, TCDD significantly induced the formation of 8-OHdG, 
and similar mean amounts of 8-OHdG were found as those in TCDD-treated intact 
female rats. However, no significant increase of 8-OHdG was detected in TCDD-treated 
OVX female rats without E2 supplement (p > 0.05). By comparing his results and ours, it 
was found that similar consistent increased trends were detected in both studies, which 
indicated that induction of hepatic 8-OHdG by TCDD in OVX female Sprague-Dawley 
rats was estrogen-dependent. This conclusion was further confirmed by the observation 
that 1.7 mg E2 supplement induced higher 8-OHdG in TCDD-treated OVX female rats 
than 0.18 mg E2 in the present study. Meanwhile, it was found that no significant increase 
of 8-OHdG was observed in TCDD treated male rats in his study and a much smaller 
increase of 8-OHdG was observed in male than in female rats in the present study, which 
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implies that the induction of 8-OHdG by TCDD was sex-dependent. Although larger 
increases of 8-OHdG were observed in TCDD treated intact and OVX rats with E2 
supplements in Wyde’s study than this study, such differences can be explained by the 
use of different  assays. The special advantage for this study is the application of UPLC 
column. With smaller particle size than the traditional LC column, UPLC column 
provides more efficient separation. In addition, sample purification was always regarded 
as an important step for the detection of DNA adducts (33-41). Moreover, mass 
spectrometry provides more chemical structural information and improves the specificity 
for the detection of DNA adducts compared with the electrochemical detectors (33-35). 
However, comprehensive evaluation of these two assays for 8-OHdG detection still needs 
further study.  
 
         Different DNA adducts have different metabolic pathways. 1, N6-εdA, AcrdG and 
CrdG are all formed by indirect oxidative stress, but 8-OHdG was formed by direct 
reaction between ROS and DNA. The dominant repair pathways for these four DNA 
adducts are also different. At present, two repair pathways are known to be responsible 
for the repair of 1,N6-εdA, base excision repair (BER) by alkyl-N-purine DNA 
glycosylase (ANPG) and direct reversal repair by oxidative demethylase of N1-
methyladenine (AlkB) (42). Multiple repair pathways are also implied in the repair of 8-
OHdG, BER mainly by OGG1, nucleotide excision repair and mismatch repair (43, 44). 
As for AcrdG and CrdG, NER is thought to be the primary repair pathway (11). Although 
different metabolic pathways exist for different DNA adducts, 8-OHdG, 1, N6-εdA, 
AcrdG and CrdG exhibit similar patterns in liver DNA of female rats following 30 weeks 
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exposure to TCDD, as shown in figures 4.2, 4.3A and 4.3B. All of them support the 
induction of oxidative DNA damage being sex- and estrogen-dependent in the liver of 
Sprague-Dawley rats following 30 weeks exposure to TCDD in this study. The only 
difference between 8-OHdG and the other DNA adducts is that higher mean levels of 
1,N6-εdA, AcrdG and CrdG were found in intact female rats than the OVX female rats 
with E2 supplement after 30-week TCDD treatment, but not 8-OHdG. 
 
         It was previously reported that the volume fraction of γ-glutamyltranspeptidase 
(GGT)–positive preneoplastic enzyme-altered hepatocellular foci (AHF), a common 
bioindicator for determining the extent and efficacy of tumor promotion, was induced 14-
fold over controls in intact female rats with p < 0.01, following 30-week exposure of 
TCDD (700 ng/kg/week) after DEN initiation (45). With 0.18 mg E2 supplement, the 
volume fraction of GGT-positive AHF was also significantly induced in TCDD treated 
OVX rats compared with their OVX control group, with p < 0.05. However, the median 
value of the volume fraction of GGT-postive AHF was much higher in TCDD treated 
intact female rats than the OVX rats with 0.18 mg E2 supplement, although large within-
group variance was found in the intact treated group (45). Without E2, no significant 
induction of AHF was observed in the TCDD treated OVX group. In addition, following 
30 weeks of TCDD exposure, the mean BrdU labeling index in intact TCDD-treated 
female rats was higher (12 ± 14.5) than in intact control fenale rats (1.6 ± 0.4), although 
no significant difference between them was found. Significantly increased BrdU labeling 
indices were observed in E2 (0.18 mg) supplemented OVX rats compared with their 
control group (45). Without E2, no significant difference of BrdU labeling indices was 
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observed between TCDD-treated OVX and the control OVX rats. By combining the 
preneoplastic AHF and cell proliferation data with our DNA adduct results, it was found 
that all of them consistently supported that the hepatoxicity associated with TCDD in 
female rats was estrogen-dependent. Oxidative DNA damage and the volume fraction of 
GGT-positive AHF consistently indicated that greater toxic effects were found in TCDD-
treated intact female rats than the OVX rats with E2 supplementation. Moreover, the 
volume fraction of GGT-positive AHF per cm3 was significantly higher in OVX control 
rats than in intact or OVX control with E2 supplementation (45), oxidative DNA adducts 
measured in this study were less definitive, which may be the result of sensitivity and 
variability issues of these biomarkers for hepatoxicity.  
 
         The volume fraction of GGT-positive AHF and BrdU labeling index were also 
determined in TCDD treated male rats by Wyde et al. (29). Although significant 
induction of the volume fraction of GGT-positive AHF was observed in TCDD-treated 
male rats without E2 supplement, only 2-fold increases were observed in these animals, 
compared to the 14-fold increase found in female rats. BrdU labeling index was 
significantly enhanced in TCDD and E2 co-treated male rats compared with its control 
group receiving the E2 supplement. Combining these results with our DNA adduct data, it 
was found that 8-OHdG was a potential biomarker capable of indicating the hepatoxicity 
of TCDD in male rats. In contrast, 1, N6-εdA was not predictive, which may be associated 
with the milder toxic effect of TCDD on the liver tissue of male rats than female rats. 
These gender differences in estrogen metabolism, especially the relative differences in 
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formation and clearance of specific active catechol estrogen metabolites are associated 
with greater oxidative stress in the females (29). 
 
         Oxidative stress induced by quinone redox cycling of estrogen metabolites has been 
regarded as one of the important potential mechanisms of estrogen carcinogenesis (46). 
The accumulation of ROS formed by the redox cycling between the o-quinones and their 
semiquinone radicals is capable of inducing oxidation of the purine/pyrimidine residues 
of DNA (47). If this mechanism is the dominant contributor for oxidative DNA damage 
in TCDD exposed hepatic tissues of female rats, equivalent of higher amounts of 
oxidative DNA adducts should be induced in TCDD treated OVX rats with E2 
supplement than the intact rats, since serum estradiol concentrations in the former were 
continuous at levels at or above peak physiological levels (30) and similar CYP450 was 
induced in the intact and OVX female rats exposed to TCDD (48). However, higher lipid 
peroxidation adducts were detected in TCDD treated intact rats than the OVX rats with 
E2 supplementation and similar amounts of 8-OHdG were found in these two groups, as 
shown in figure 4.2, 4.3A and 4.3B. These results imply that the effect of estrogen on 
oxidative DNA damage cannot completely explain the differences in oxidative DNA 
damage induced in these two groups. Other unknown contributors may exist, which also 
induced oxidative DNA damage in intact female rats with TCDD promotion. 
  
         Oxidative DNA damage was induced in rodents exposed to TCDD probably by 
enhancing oxidative stress and up-regulation of CYP450 (17-19). The dose-responses of 
CYP1B1, CYP1A1 and CYP1A2 were characterized in the liver of female Sprague-
 128
Dawley rats following 30-week exposure to TCDD with DEN initiation (48). Immunoblot 
analysis showed that the protein levels for CYP1B1, CYP1A1 and CYP1A2 exhibited a 
dose-dependent induction by TCDD with more induction of CYP1A1 and 1A2, than 1B1. 
CYP1A1 catalyzes the metabolic activation of many chemicals, which may contribute to 
the formation of active carcinogens, such as PAHs (49). CYP1A1 and 1B1 induction 
occurs in virtually every tissue of the body after TCDD exposure (50). CYP1A2 was 
found to be linked to TCDD-inducible TCDD binding in the liver. Mice with the intact 
CYP1A2 genes had 10 times more TCDD in total liver and concentration than was 
present in knockout mice (51).  The induction of CYP1A1 by TCDD was associated with 
oxidative DNA damage in the Hepa1c1c7 cell line (52). No significant difference was 
found for lipid peroxidation, indicated by thiobarbituric acid-reactive substances and 
reduction of cytochrome C, in CYP1A2 knockout mice and their parental lineage strains 
following a single oral dose of TCDD (25 µg/kg) (53).  To date, no connection between 
induction of CYP1B1 and oxidative stress in rodents following TCDD exposure has been 
determined.   Therefore, it is still unclear how these enzymes contribute to oxidative 
stress, including oxidative DNA damage and hepatic carcinogenesis of TCDD in female 
rats.  
 
         The mechanisms for TCDD-estrogen interactions appear to be tissue specific in 
female Sprague-Dawley rats, which may contribute to the extent of oxidative DNA 
damage induced in hepatic DNA of these animals. Liver contains a fully functional 
estrogen receptor (ER), with similar characteristics to those identified for ER in 
mammary gland and uterus. Liver also showed high affinity binding for E2 and other 
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potent estrogens (2). TCDD decreases rat hepatic ER in both chronic and acute exposure 
experiments, which was also shown in certain AhR-dependent ways (2). In addition to 
effects on hepatic ER, the up-regulation of CYP450 by TCDD may enhance the 
metabolism of hepatic estrogen, especially by CYP1A1/1A2 and CYP1B1. CYP1A1/1A2 
and CYP1B1 selectively catalyze hydroxylation at the 2- and 4-postions of estrone (E1) 
and E2 respectively, which can be further oxidized into ο-quinones in vivo, as shown in 
figure 4.5 (46). ο-Quinones can undergo redox cycling with the semiquinone radical 
generating superoxide radicals mediated through CYP450 and enhance oxidative DNA 
damage (46). The connection between 4-hydroxyestradiol or E2 and oxidative stress has 
been observed in several studies (54-56). But very limited studies were available for 
comparison of oxidative stress induced by 2- (2-OHE1/E2) and 4-hydroxylated E1 or E2 
(4-OHE1/E2) except the in vitro study by Han et al. (57). However, in his study, only 8-
OHdG was monitored to evaluate the oxidative DNA damage and the difference of 
induced 8-OHdG between 2-OHE1/E2 (2-OHE1, 1.00 ± 0.53/105 dG; 2-OHE2, 0.71 ± 
0.28/105 dG) and 4-OHE1/E2 (4-OHE1, 1.62 ± 0.79/105 dG; 4-OHE2, 1.27 ± 0.31/105 dG) 
exposed group was not high. The much higher amounts of 8-OHdG presented in this 
paper suggest a prominent amount of artifact in this study. Besides oxidative DNA 
damage induced by quinone redox cycling, estrogen quinones can also directly damage 
cellular DNA and form bulky DNA adducts, as shown in figure 4.5 (57, 58). However, 
the number of E1/E2-2, 3-Q adducts were considerably lower than corresponding adducts 
from E1/E2-3, 4-Q (58). Several studies have confirmed the importance of 4-OHE1/E2 and 
their bulky DNA adducts during estrogen carcinogenesis (59-62). At present, the relative 
promutagenic properties of these two bulky classes of DNA adduct remain unclear (63, 
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64). By altering the metabolism of estrogen in female rats, the relative contribution of 
oxidative DNA damage and bulky DNA adducts induced by estrogens in TCDD hepatic 
carcinogenesis is still unknown. 
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+ 17β-estradiol
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Male rats were treated by A, B, C, D four different exposure scenarios with 0.18 mg 17β-
estradiol; OVX female rats were treated by A, B, C, D four scenarios with both 0.18 and 1.7 
mg 17β-estradiol; intact female rats were treated by A and C exposure scenarios. 
 
Figure 4.1 The experiment design of this study 
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comparison between treated and control groups:   *,  p<0.05; ns, no significant difference, p>0.05 
 
Group 1, vehicle control group for intact female rats with DEN initiation; Group 2, 700 ng/kg/week 
TCDD treated group of intact female rats with DEN initiation; Group 3, vehicle control group for 
OVX female rats with DEN initiation; Group 4, 700 ng/kg/week TCDD treated group of OVX 
female rats with DEN initiation; Group 5, vehicle control group of OVX female rats with 0.18 
mg/pellet E2 supplement and DEN initiation; Group 6, 700 ng/kg/week TCDD treated group of 
OVX female rats with 0.18mg/pellet E2 supplement and DEN initiation; Group 7, vehicle control 
group for OVX female rats with 1.7 mg/pellet E2 supplement and DEN initiation; Group 8, 700 
ng/kg/week TCDD treated group of OVX female rats with 1.7 mg/pellet E2 supplement and DEN 
initiation. 
Figure 4.2 8-OHdG in the liver of intact or OVX female Sprague-Dawley rats 
n=6~8 
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Group 1, vehicle control group for intact female rats with DEN initiation; Group 2, 700 ng/kg/week 
TCDD treated group of intact female rats with DEN initiation; Group 3, vehicle control group for 
OVX female rats with DEN initiation; Group 4, 700 ng/kg/week TCDD treated group of OVX 
female rats with DEN initiation; Group 7, vehicle control group for OVX female rats with 1.7 
mg/pellet E2 supplement and DEN initiation; Group 8, 700 ng/kg/week TCDD treated group of 
OVX female rats with 1.7 mg/pellet E2 supplement and DEN initiation. 
Figure 4.3A 1, N6-εdA in the liver of intact or OVX female Sprague-
Dawley rats 
n=5~8 
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OVX female rats with DEN initiation; Group 4, 700 ng/kg/week TCDD treated group of OVX 
female rats with DEN initiation; Group 7, vehicle control group for OVX female rats with 1.7 
mg/pellet E2 supplement and DEN initiation; Group 8, 700 ng/kg/week TCDD treated group of 
OVX female rats with 1.7 mg/pellet E2 supplement and DEN initiation. 
Figure 4.3B AcrdG and CrdG in the liver of intact or OVX female 
Sprague-Dawley rats 
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Figure 4.4 8-OHdG and 1, N6-εdA in the hepatic DNA of male Sprague-Dawley rats 
n=4~5 
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comparison between treated and control groups:   *,  p<0.05; ns, no significant difference, p>0.05 
 
Group 1, vehicle control group for intact male rats with DEN initiation; Group 2, 700 ng/kg/week 
TCDD treated group of intact male rats with DEN initiation; Group 3, vehicle control group for 
male rats with 0.18 mg/pellet E2 supplement and DEN initiation; Group 4, 700 ng/kg/week TCDD 
treated group of male rats with 0.18 mg/pellet E2 supplement and DEN initiation. 
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Figure 4.5 The formation of ROS and bulky DNA adducts by estrogen 
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CHAPTER V 
OXIDATIVE DNA DAMAGE IN THE LIVER OF FEMALE SPARAGUE-DAWLEY 
RATS CHRONICALLY EXPOSED TO POLYHALOGENATED AROMATIC 
HYDROCARBONS (PHAHS) 
 
A. INTRODUCTION 
 
         Oxidative stress is thought to play an important role in many diseases including 
cancer, neurodegeneration and aging (1). Many endogenous processes, as well as 
exogenous chemicals or their metabolites, are known to induce ROS, which can interact 
with cellular constituents, especially lipids and nucleic acids, and further induce various 
DNA adducts (1). To date, several DNA adducts are considered as key endogenous DNA 
adducts induced by ROS. They include 8-OHdG, 1, N6-εdA, N2, 3εG, 1, N2-εdG, M1dG, 
acrolein derived dG adduct (AcrdG), crotonaldehyde derived dG adduct (CrdG) and 4-
HNE derived dG adduct (4-HNEdG) (2-3, 31-35). Site-directed mutagenicity studies 
found that these DNA adducts can induce specific transition and/or transversion point 
mutations in bacteria and/or mammalian cells (4-6, 39), which contributes to the 
formation of a hypothesis that the accumulation of ROS-induced DNA damage can 
induce cancer. Meanwhile, growing evidence supports that these promutagenic DNA 
adducts are significantly induced in patients with various chronic inflammatory diseases, 
including cancer (2, 6, 36-38). Although DNA adduct formation is generally regarded as 
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an important stage for the carcinogenesis of genotoxic environmental chemicals, it may 
also be an important contributor for the tumorgenesis of nongenotoxic chemicals, 
especially chemicals which can induce endogenous active metabolites and ROS in the 
promotion and progression stages of carcinogenesis, such as polyhalogenated aromatic 
hydrocarbons (PHAHs) (7, 47-52).  
 
         PHAHs comprise a large class of compounds, including polychlorinated 
dibenzodioxins (PCDDs), polychlorinated dibenzofurans (PCDFs) and polychlorinated 
biphenyls (PCBs) (8). They are one of the most prevalent groups of pollutants in the 
environment. PCDDs and PCDFs have no industrial use, but are produced as unwanted 
by-products of many anthropogenic activities, such as chlorine bleaching of paper and 
pulp and combustion of wastes and fuels (8). PCBs were commercially produced and 
widely used for various industrial purposes, including heat transfer agents, dielectric 
insulating fluids for capacitors and transformers, plasticizers, and paint additives (9). 
Because these compounds are resistant to degradation and persistent in environment, they 
have the ability to bioaccumulate and concentrate in humans and animals, which may 
result in chronic lifetime exposure, possible toxicity and carcinogenicity (8-10). 
Depending on the site and type of the halogenation, some PHAHs induce a similar 
spectrum of biochemical and toxic responses in experimental animals. They are regarded 
as mediated through a common mechanism of action initiated by binding to a cytosolic 
receptor known as the aryl hydrocarbon receptor (AhR) and triggering the expression of a 
variety of genes, the so-called AhR gene battery (10). 2, 3, 7, 8-Tetrachlorodibenzo-p-
dioxin (TCDD), commonly referred to as “dioxin,” is the prototype of these structurally 
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related compounds and exhibits the highest potency of binding to the AhR. Therefore, 
these structurally related compounds are commonly referred to as dioxin-like compounds 
(DLCs). Due to similarity in toxicity and its mechanisms, the concept of toxic 
equivalency factors (TEF) has been used for the assessment of risk and regulatory control 
for dioxin-like compounds (DLCs) (10). By using those factors, the toxicity of a PHAHs 
mixture is expressed in terms of its total toxic equivalent quotient (TEQ), which is the 
amount of TCDD that would produce the equal toxic effect of all contributing congeners 
within the mixture.  
 
         The association of oxidative stress and PHAHs, especially TCDD, has been studied 
for several decades (11-13). Substantial evidence has accumulated to support that TCDD 
can induce oxidative stress in vitro, mammalian cells and rodents. Different biomarkers 
have been applied to assess the oxidative stress induced by TCDD (11), including hepatic 
lipid peroxidation (LPO), DNA single strand breaks, hepatic membrane fluidity, 
glutathione, nonprotein sulfhydryl, and NADPH.  Significantly increased LPO with large 
strain differences was also detected in other organs of rats and mice exposed to TCDD, 
including kidney, thymus, heart, tests and brain (11). Similarly, PCB-induced oxidative 
stress was also observed in multiple studies (14-19). These studies indicated that 
oxidative stress is a ubiquitous side effect produced by these compounds. Although many 
PHAHs have been shown to have very weak initiating activity without direct genotoxic 
effects, it has been postulated that they may be indirectly genotoxic through the formation 
of ROS-induced DNA adducts (11-19). Because TEF has been widely applied for 
evaluation of the toxic effects of PHAHs and oxidative stress is universally induced in 
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animals exposed by these compounds, it is meaningful to evaluate the application of the 
TEF approach in the toxicity of PHAHs using oxidative DNA lesions, especially in 
chronic animal toxicity and carcinogenesis studies. 
 
         In cooperation with National Toxicology Program (NTP), multiple oxidative DNA 
lesions were measured in liver DNA of female Sprague-Dawley rats following 53 weeks 
of exposure of PHAHs by a battery adduct assays. Several typical PHAHs were selected 
as model compounds in NTP’s studies, including TCDD, 3,3΄,4,4΄,5-pentachlorobiphenyl 
(PCB126), 2,3,4,7,8-pentachlorodibenzofuran (PeCDF) and 2,2΄,4,4΄,5,5΄-
Hexachlorobiphenyl (PCB153). PCB126 is a non-ortho-substituted PCB with TEF value 
of 0.1. As the most potent DLC in the environment, PCB126 accounts for 40% to 90% of 
the toxic potency of dioxin-like PCBs (26).  PeCDF, with a TEF value of 0.5, represents 
the most potent PCDF present in human tissues. PCB153 is a di-ortho-substituted 
nonplanar PCB with the highest concentrations in human samples on a molar basis with 
no TEF value (27). The structures of these compounds are shown in figure 5.1. In order 
to evaluate the TEF approach in assessing of the carcinogenesis of PHAHs mixtures, 
female Sprague-Dawley rats were exposed to the ternary mixture of TCDD, PCB126 and 
PeCDF, the binary mixture of PCB153 and PCB126, as well as PCB153 alone, PCB126 
alone and TCDD alone in NTP’s studies (8). An important assumption for TEF 
methodology is that the toxicity of DLCs mixture is dose additive based on the TEF value 
of the individual component. This study will evaluate this assumption from the standpoint 
of oxidative DNA damage induced and its relationship to toxicity and carcinogenicity of 
PHAHs. Since different DNA adducts have different formation and repair pathways in 
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vivo, the application of this oxidative DNA adduct battery will provide more 
comprehensive information on oxidative DNA damage to estimate the toxicity of PHAHs. 
This will improve the scientific basis of human risk assessment of PHAHs in 
environment. 
 
B. MATERIALS AND METHODS 
 
Chemicals 
  
         Nucleic acid purification grade lysis buffer, protein precipitation solution and 
proteinase K were purchased from Gentra Systems (Minneapolis, MN). Other chemical 
reagents without further explanation were from Sigma-Aldrich Chemical Company (St 
Louis, MO). HPLC grade water, methanol and other similar chemical solutions were 
from Thermo Fisher Scientific Company (Raleigh, NC). 15N5-1, N6-εdA standard was 
synthesized and characterized as described by Ham et al. (20). 15N5-8oxodG, 15N5-dG and 
13C10-dG were purchased from Cambridge Isotope Laboratories (Andover, MA, USA). 1, 
N2-εdG and 13C10-1, N2-εdG were synthesized as reported by Kusmierek et al. (21). MDA 
modified 15N5 and 14N5 DNA was made by the method of Jeong’s (22). AcrdG, CrdG and 
4-HNEdG standards and their 15N5 labeled internal standards were synthesized according 
to previous studies (23-25). 
 
Animal exposures 
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          Rat liver tissues were provided by NTP Battelle Laboratories (Columbus, OH), 
which conducted the studies according to NIEHS contract (N01-ES-75411) (8, 26, 27, 61, 
65). Female Sprague-Dawley rats were exposed to one of the following materials by 
gavage 5 days per week for 53 weeks: PCB 153 alone, PCB 126 alone, TCDD alone, the 
binary mixture of PCB153 and PCB126 or the ternary mixture of TCDD, PCB126 and 
PeCDF. The TEQ doses used for TCDD and the ternary mixture were 0, 22, 46 and 100 
ng/kg/day body weight. The doses used for PCBs were 0, 300 and 1000 ng/kg/day body 
weight for PCB126, and 0, 550 and 1000 µg/kg/day for PCB 153. In addition, oxidative 
DNA damage was also measured in liver DNA of rats receiving the following dose of the 
binary mixture of PCB153 (µg/kg/day) and PCB126 (ng/kg/day), 0+0 and 1000+1000. 
Liver tissues were collected from 5~8 female rats per group one day after the final 
exposure and stored frozen at -80 ˚C. 
 
DNA isolation 
 
         400 mg tissue samples in 6 ml PBS solution was homogenized by a Tehran 
homogenizer (Wheaton Instruments, Millville NJ) and then centrifuged at 1700 g for 5 
min. After decanting the supernatant, the formed nuclear pellet was suspended in cell 
lysis buffer. Proteinase K (400 U/ml) was added and samples were rotated overnight in 4 
˚C cold room. On the second day, protein was removed by protein precipitation solution. 
Then the sample was washed with isopropanol and 70% ethanol subsequently. RNase A 
was added into the sample before incubation for 30 min at 37 ˚C. Finally, DNA of high 
purity was obtained and suspended in water at -80 ˚C until adducts analysis. Besides, 
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TEMPO (20mM final concentration in the sample) was present during the entire DNA 
isolation process to inhibit the possible formation of free radical species. 
 
Enzymatic digestion and HPLC purification 
 
         Slightly different enzyme digestion and HPLC purification approaches were applied 
for different DNA adducts. Considering the possibility of artifact formation of 8-OHdG 
during sample work-up, a quick assay was developed especially for the detection of this 
adduct. The enzymatic hydrolysis was slightly modified based on Pang’s studies (3). 100 
µg DNA was dissolved in sodium acetate buffer I (sodium acetate 30mM, pH 5.6, 0.2 
mM zinc chloride) and incubated at 37 ˚C for 1 h with addition of nuclease P1 (5 µg). 20 
units of alkaline phosphate (AP) and 0.0118 units of phosphodiesterase (PDE) were 
added into the sample with sodium acetate buffer II (sodium acetate 30mM, pH 8.1) and 
incubated for additional 1 h at 37 ˚C. 5 µl TEMPO (200 mM), and 15N5-8-OHdG were 
added to the sample at the beginning of the digestion. A similar digestion procedure was 
used for 1, N6-εdA and AcrdG, 1, N2-εdG, M1dG, CrdG or 4-HNEdG, except that DNase 
I (200 U) was added for the propano adducts. The mixture of 15N5-AcrdG, 15N5-CrdG, 
15N5-4-HNEdG (50 fmol for each) and malondialdehyde (MDA) modified IS DNA 
corresponding to 100 fmol of 15N5-M1dG was added to the sample at the beginning of the 
digestion. The proteins were removed by micron-10 filter and the hydrolysate was 
concentrated by speed vacuum before HPLC sample purification.  
 
         Different HPLC purification methods were developed for these DNA adducts. A 
short LC gradient program was applied to purify the sample for 8-OHdG and 1, N6-εdA. 
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The fractions containing them were collected based on retention time of standards on the 
Agilent 1200 Series analytical fraction collector system. All nucleosides were monitored 
by UV at a wavelength 264 nm. The separation was performed on Atlantis T3 (5 µm, 4.5 
× 150 mm) column at 30 ˚C with flow rate of 1 ml/min. Mobile phases A and B were 10 
mM ammonium acetate in water and 100% methanol, respectively. The elution started 
with 5% B held for 5 min, increased to 10% in 5 min, 20% in 10 min and 80% in the next 
10 min before returning to 5% in the final 10 min. Using the same mobile phase and 
column, the fractions containing CrdG and 4-HNEdG were collected by a different LC 
program. The initial conditions were 35% B with the flow rate of 0.5 ml/min for 10 min. 
From 10 to 25 min, B was increased to 70% and held for 10 min before returning to 35% 
in the final 15 min. For LC purification of 1, N2-εdG, AcrdG and M1dG, mobile phase A 
was 5 mM ammonium formate with 0.1% formic acid in water (pH 3.5); mobile phase B 
was 100% methanol. The sample was separated with the initial condition 10% B at flow 
rate 0.6 µl/min. From 5 to 17 min, B was increased to 30%, held for 10 min and then 
increased to 60% for 10 min to clean the column before returning to 10%. 
 
LC-MS/MS detection 
 
           Two different systems were applied for detect the ROS-induced DNA adducts, 
UPLC-MS/MS and nanoUPLC-MS/MS. The UPLC-MS/MS system, consisting of 
Aquity UPLC system (Waters, Milford, Massachusetts) and TSQ-Quantum ultra triple 
quad mass analyzer (ThermoFinnigan, San Jose, CA), was applied for the measurement 
of 8-OHdG. The Sample was separated on a T3 HSS column 2.1×100mm at a flow rate 
of 200µl/min. A nanoUPLC-MS/MS system, comprised of 10kpsi nanoacquity Ultra 
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performance LC system (Waters, Milford, Massachusetts) and a TSQ-Quantum ultra 
triple quad mass analyzer (ThermoFinnigan, San Jose, CA), was applied to detect the 
remaining adducts. For 1, N6-εdA analysis, mobile phase A was 5 mM ammonium 
formate in water and B was 1% formic acid in acetonitrile.  For 1, N2-εdG, M1dG, AcrdG, 
CrdG and 4-HNEdG, mobile phase A and B were 0.1% formic acid in water and 
acetonitrile respectively. The sample was first loaded on the trap column by 99% A in the 
first 3 min with flow rate 5 µl/min. Then the trap column was connected to the analytical 
column through the trap valve in the following analysis.  For 1, N6-εdA, 1, N2-εdG, M1dG, 
and AcrdG assay, the flow rate was 1.0 µl/min with the gradient program 95% A for 1 
min and a linear decrease of phase A from 95% to 70% in 10 min before reconditioning 
in 95% A for 15 min. For CrdG assay, the flow rate was 1.0 µl/min and the gradient 
program was 90% A for 1 min, decreasing to 50% A in 10 min and held for 5 min before 
returning to 90% A. For 4-HNEdG assay, the gradient program was 85% A for 2 min, 
decreasing to 30% over the next 10 min. Similar MS parameters were utilized for 1, N6-
εdA, 1, N2-εdG, M1dG, AcrdG, CrdG and 4-HNEdG monitoring the appropriate 
transitions in SRM mode. The capillary temperature was 285 ˚C. The spray voltage was 
1500 V. Neither nebulizing nor drying gas was applied in this system. With positive ESI 
mode and collision energy 16 eV, two transitions were monitored for the detection of 1, 
N6-εdA, 1, N2-εdG, M1dG and 4-HNEdG respectively, m/z 276.0 → 160.0 and 281.0 → 
165.0 for 1, N6-εdA, m/z 304.0 → 188.0 and 308.0 → 193.0 for M1dG, m/z 292.0 → 
176.0 and 302.0 → 181.0 for 1, N2-εdG and m/z 424.0 → 308.0 and 429.0 → 313.0 for 4-
HNEdG. Three and four transitions were monitored for CrdG and AcrdG detection 
respectively, m/z 338.0 → 222.0, 343.0 → 227.0 with collision energy 12 eV and m/z 
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338.0 → 178.0 with collision energy 32 eV for CrdG, m/z 324.0 → 208.0, 329.0 → 213.0 
with collision energy 12 eV and 324.0 → 164.0, m/z 329.0 → 190.0 with collision energy 
32eV for AcrdG. The transitions with collision energy 12 eV were used for quantification 
of these two adducts. 
 
N2, 3-εG assay 
 
         Briefly, 200 fmol of 13C415N2-N2, 3-εG was spiked into 250 µg DNA and incubated 
at 100 ˚C for 40 min. After neutral thermal hydrolysis, the DNA backbone was removed 
by micron 10 filters and the hydrolysate was enriched in analyte on a Beckman 
Ultrasphere C18 column (5 µ, 250 x 4.6 mm). The fraction containing N2, 3-εG was 
collected by Agilent 1200 HPLC system. Mobile phase A and B were 10 mM ammonium 
acetate in water and methanol respectively. The sample was then analyzed on a Waters 
Acquity UPLC coupled to a Thermo Finnigan TSQ Quantum Ultra triple-quadrupole 
mass spectrometer.  Separation was performed on an Aquasil 10 mm i.d. C18 column (3 
µ, 150 x 1mm) at a flow rate of 0.05 ml/min with 0.1% acetic acid in water as phase A 
and acetonitrile as phase B. Similar MS parameters were utilized to detect N2, 3-εG to 8-
OHdG. The transitions monitored were m/z 176.0 → 176.0 for N2, 3-εG, and m/z 182.0 
→ 182.0 for 13C415N2-N2, 3-εG. 
 
Statistical analysis 
 
         Statistical analyses were performed using R (version 2.11). The effect of chemical 
exposures on the accumulation of DNA adducts was assessed with nonparametric 
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isotonic (monotonic) regression model, and p-values were calculated based on 100,000 
permutations (28). A p-value ≤ 0.05 was considered as a positive association between the 
level of DNA adducts and PHAHs exposure. Considering the nonhomogenous variance 
and the limited sample size in some groups, the nonparametric Wilcox Rank Sum test 
was used to assess the differences of DNA adduct concentrations between control and 
PHAHs treated rats.  Multiple comparisons across pairwise Wilcox Rank Sum tests were 
adjusted by calculating permutation p-values using 100,000 permutations (29). Two-
sided and one-sided p values were considered significant if they were ≤ 0.05. 
 
C. RESULTS 
 
         Following 53 weeks exposure, increases of 1, N6-εdA, N2, 3-εG and 8-OHdG were 
observed in liver DNA of female rats treated with 1000 µg/kg/day PCB153, although 
they did not reach statistical significance, as shown in figure 5.2. About a 2-fold increase 
of 8-OHdG was found in the 1000 µg/kg/day PCB153 exposed group (1.2 ± 0.49 
adduct/106 unmodified nucleosides), compared with 0.59 ± 0.07/106 unmodified 
nucleosides in the control. Slight increases of 1, N6-εdA and N2, 3-εG were also observed 
in these two groups, with 0.55 ± 0.7 adduct/108 unmodified nucleosides in the exposed 
and 0.27 ± 0.11/108 unmodified nucleosides in the control for 1, N6-εdA, 0.69 ± 0.12 
adduct/108 unmodified nucleosides in the exposed and 0.4 ± 0.1/108 unmodified 
nucleosides in the control for N2, 3-εG. No significant increase of these three adducts was 
found in the 300 µg/kg/day PCB153 exposed group compared with their control group. 
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Among these three adducts, the amount of 8-OHdG was the highest, almost 100 times 
higher than those of 1, N6-εdA and N2, 3-εG in the control animals.  
 
         53-week exposure to PCB126 at 1000 ng/kg/day induced a significant increase in 1, 
N6-εdA from 0.48 ± 0.09 adduct/108 unmodified nucleosides in the control group to 1.09 
± 0.33/108 unmodified nucleosides in the treated group (p = 0.02). Induction of N2, 3-εG 
(p = 0.07) and 8-OHdG (p = 0.08) were also observed in the liver DNA of these female 
rats, as depicted in figure 5.2. 8-OHdG was increased to 1.7 ± 0.76 adduct/106 
unmodified nucleosides relative to 1.1 ± 0.38 adduct/106 unmodified nucleosides in the 
control group. N2, 3-εG increased to 0.69 ± 0.15 adduct/108 unmodified nucleosides in 
the exposed group relative to 0.45 ± 0.08 adduct/108 unmodified nucleosides in the 
control group.  In addition, a significant increase of 1, N6-εdA was also observed in the 
group exposed to PCB 126 at 550 ng/kg/day, with the mean value 1.04 ± 0.26 adduct/108 
unmodified nucleosides. No significant difference for either of these three adducts was 
found between the two PCB126 exposure groups at 1000 ng/kg/day and 550 ng/kg/day. 
 
         Following 53-week exposure to the binary mixture of PCB153 (1000 µg/kg/day) 
and PCB126 (1000 ng/kg/day), 8-OHdG, 1, N6-εdA and N2, 3-εG were all significantly 
increased in liver DNA of female rats, compared to the respective control groups, as 
shown in figure 5.3. More than a 2-fold increase of 8-OHdG was present in the exposed 
group (3.33 ± 0.59 adduct/106 unmodified nucleosides), compared with the control (1.24 
± 0.16 adduct/106 unmodified nucleosides). Likewise, significant increases of 1, N6-εdA 
(1.09 ± 0.22 adduct/108 unmodified nucleosides in the exposed, 0.52 ± 0.17 adduct/108 
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unmodified nucleosides in the control) and N2, 3-εG (0.70 ± 0.21 adduct/108 unmodified 
nucleosides in the exposed, 0.32 ± 0.07 adduct/108 unmodified nucleosides in the control) 
were also observed in the exposed samples compared with their controls. The mean 
background level of 8-OHdG was the highest of the three adducts in the control animals, 
more than 100 times higher than the other two. 
 
         Following 53-week exposures of TCDD by gavage, slight increases of 8-OHdG 
were observed in all TCDD exposed groups as shown in figure 5.4, although no 
significant increase was observed in all exposed groups compared with the control. The 
highest 8-OHdG was detected in 1000 ng/kg/day TCDD exposed group, 1.93 ± 0.33/106 
unmodified nucleosides. 1, N6-εdA was significantly induced in the liver of all female 
rats after TCDD exposure, compared with the control group. Unexpectedly, the highest 
mean level of 1, N6-εdA was observed in the exposed group with the dose of 22 (1.58 ± 
0.39 adduct/108 unmodified nucleosides) and 46 ng/kg/day (1.52 ± 0.57 adduct/108 
unmodified nucleosides) instead of the highest dose 100 ng/kg/day (0.53 ± 0.13 
adduct/108 unmodified nucleosides), as shown in figure 5.4. In addition, a significant 
positive association was found between the dose of TCDD and the number of 1, N6-εdA 
adducts in the exposed animals (p = 0.0006), which was not observed for 8-OHdG. 
 
         Following 53-week exposure of the ternary mixture of TCDD, PCB126 and PeCDF, 
a significant increase in 8-OHdG was only observed in the highest TEQ dose group, 100 
ng/kg/day. The mean value of 8-OHdG in 100 ng/kg/day ternary mixture exposed groups 
was 2.4 ± 0.4 adduct/106 unmodified nucleosides, with 1.4 ± 0.1 adduct/106 unmodified 
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nucleosides in the control group. In contrast, 1, N6-εdA showed a significant increase 
even at 22 ng/kg/day (0.98 ± 0.29 adduct/108 unmodified nucleosides) compared with the 
control group (0.23 ± 0.14 adduct/108 unmodified nucleosides), besides the doses of 46 
(1.24 ± 0.41 adduct/108 unmodified nucleosides) and 100 ng/kg/day (1.03 ± 0.22 
adduct/108 unmodified nucleosides), as shown in figure 5.4. The significant positive 
association was found for both 8-OHdG and 1, N6-εdA with the TEQ dose of all the 
ternary mixture exposed animals (p <0.0001). 
 
         Several other DNA adducts induced by lipid peroxidation products were also 
measured in the liver DNA of control and 100 ng/kg/day TCDD or the ternary mixture 
exposed female rats, which included 1, N2-εdG, M1dG, AcrdG, CrdG and 4-HNEdG. The 
results are shown in figure 5.5. Following 53-week exposure, none of these adducts 
showed significant increases in the TCDD treated female rats. On the contrary, 
significant increases were observed for CrdG and 1, N2-εdG in the ternary mixture 
exposed animals. Induction of AcrdG (p = 0.07) and M1dG (p = 0.08) were also observed 
in these groups. More than 3-fold increases of M1dG and AcrdG were found in the 100 
ng/kg/day ternary mixture exposed animals followed by approximately 2-fold increases 
of 1, N2-εdG, CrdG and 4-HNEdG compared with the control group. 
 
D. DISCUSSION 
           
         Mutation studies have suggested that oxidative stress, especially from chronic 
inflammation, has been associated with carcinogenesis (1). Since the induction of cancer 
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is a multistage process characterized by accumulation of genetic changes, much effort has 
been focused on understanding the effects of DNA damage and induction of mutations. 
At present, oxidative DNA damage is generally regarded as a major source of mutations 
in living organisms, which includes base modifications (DNA adducts), 2´-deoxyribose 
modification, DNA strand breakage and DNA cross-linking (30). Among them, DNA 
adducts are the most widely applied biomarkers in carcinogenesis studies (2, 3, 6, 31-33, 
35-39). 8-OHdG is presently the most extensively studied and most abundant oxidative 
DNA adduct in vivo. It has been shown to induce G to T transversions in both bacterial 
and mammalian cells (37). Many assays have been developed to detect this DNA adduct 
in animal or human tissues, such as LC-ECD (electrochemical detector), immunoassay 
and LC-MS/MS (6, 36, 37, 40), but the artifactual formation during sample working-up 
has hampered its application as a reliable biomarker (40). 1, N6-εdA is another popular 
biomarker, widely applied to evaluate the oxidative DNA damage in animal or human 
tissues (2). As one of the DNA adducts induced during lipid peroxidation (LPO), its 
background level is much lower than 8-OHdG in vivo.  Similar to 8-OHdG, 1, N6-εdA 
can induce multiple single base changes, with A to G transitions as the dominant 
mutation. Compared with 1, N6-εdA, other etheno adducts are less widely studied in 
carcinogenesis, but all of them have promutagenic properties. Different from etheno 
adducts, the mutation study on propano adducts is still under development and the 
promutagenic properties for some of them have been demonstrated (39). Besides 
differences in promutagenic properties, different DNA adducts have different formation 
pathways in vivo. Considering these differences between oxidative DNA adducts, 
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multiple adducts were measured in this study to provide a more comprehensive profile of 
the oxidative DNA damage in the liver of female rats exposed to PHAHs. 
 
         PHAHs are predominant nongenotoxic pollutants in environment, and thus their 
mechanism of carcinogenesis has been studied for decades (41-46). Although several 
studies indicated no direct genotoxic effects induced by PHAHs, some studies found the 
induction of oxidative stress by these compounds, which may cause oxidative DNA 
damage and thereby contribute to their toxicity indirectly (7, 11-19, 47-53). Among them, 
TCDD is the most studied. The oxidative DNA damage induced by TCDD has been 
measured in vitro, in cell culture and in animal studies (7, 47-49, 53, 54). However, most 
of the studies were high dose acute studies. Similar to some other toxic effects of TCDD, 
oxidative DNA damage and oxidative stress was also thought to be associated with AhR 
and activation of CYP450, especially CYP1A1 (13, 54, 55). The up-regulation of these 
enzymes triggered changes in metabolism of endogenous compounds in vivo, which 
resulted in oxidative DNA damage. The TEF methodology was developed based on the 
AhR affinity of PHAHs. Therefore, we hypothesized that oxidative DNA adducts would 
be highly correlated with the predictions based TEFs for PHAHs.  
 
         Using a battery of assays for oxidative DNA adducts, the oxidative DNA damage 
induced by PCB153 was measured in the liver of Sprague-Dawley rats after 53-weeks of 
exposure. Although PCB153 does not have a TEF value, it slightly increased oxidative 
DNA damage at the highest dose evaluated, 1000 µg/kg/day, as indicated by 8-OHdG, N2, 
3-εG and 1, N6-εdA in figure 5.2. Using the same animal tissues, no increase of M1G was 
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observed in a previous study (51). As a non-dioxin like compound, the mechanism of 
oxidative stress induced by PCB153 was regarded as regulated by AhR-independent 
pathway. PCB153 is a phenobarbital-like inducer of hepatic CYP450, which may 
significantly induce CYP450 other than CYP1A1 and 1A2 (27) and increase endogenous 
metabolites that result in reactive oxygen species. With a single i.p. dose of PCB153 (150 
µg/kg) in male Sprague-Dawley rats, increased hepatic lipid peroxidation was found by 
Fadhel et al. (56). More than 2 fold increases of thiobarbituric acid reactive substances 
(TBARS) were detected in the liver of male rats after 150 µmol/kg PCB153 exposure for 
6-days. Significant increases of glutathione-S-transferase activity were also observed in 
acute animal studies by Lamartiniere et al. (57). Subchronic PCB 153 exposure (13 
weeks) significantly induced treatment-related depletion of hepatic vitamin A in both 
male and female Sprague-Dawley rats exposed to 50 ppm PCB 153 in the diet (58). 
However, a high dose chronic exposure to PCB153 seemed necessary for induction of 
oxidative DNA damage in our study. These results indicate that an AhR-independent 
pathway is capable of inducing oxidative DNA damage in the liver of PCB 153 exposed 
rats, since ROS can be enhanced by multiple pathways in biological systems (1). 
 
          Compared with PCB153, a 53-weeks exposure to PCB126 induced higher amounts 
of oxidative DNA damage, as indicated by 8-OHdG and 1, N6-εdA in figure 5.2. Hassoun 
et al. studied the abilities of 13-week and 32-week exposure of PCB126 to induce 
oxidative stress in hepatic tissues of female rats (19, 49, 59). In their studies, 
approximately 2-fold increases in the production of superoxide anion and lipid 
peroxidation were observed in both 13-week and 32-week PCB126 (1000ng/kg/day) 
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exposed female rat livers. DNA single-strand breaks were also significantly induced in 
the PCB126 exposed samples, with slightly more than 3-fold increases, compared with 
the control groups. Previously, less than 2-fold increases of M1G were found in the liver 
DNA of female rats after 53-week PCB126 (1000ng/kg/day) exposures (51). Moreover, 
dose-related increases in active acute and subchronic to chronic inflammation was 
observed in the livers of high dose PCB126 treated animals after 31, 53 and 2-year 
exposure in the NTP studies (26). Collectively, these results provide strong support for 
the involvement of oxidative stress and oxidative DNA damage in the toxicity of PCB126.  
 
         As shown in figure 5.6, after 53-weeks exposure to PCB153, no dose-dependent 
increases in hepatocellular adenoma or cholangiocarcinoma were observed in PCB153 
exposed animals. Different from PCB153 exposed animals, increased incidences of both 
cholangiocarcinoma and hepatocellular adenoma were observed in all groups of PCB126 
exposed animals after 53-week exposures, with the highest incidence in the group 
exposed to the highest dose (p<0.05). Therefore, our oxidative DNA adduct data 
consistently agreed with the relative carcinogenicity of PCB153 and PCB126 as 
evaluated by tumor incidence. As shown in figure 5.6, significant induction of CYP1A1, 
evaluated by 7-ethoxyresorufin-O-deethylase (EROD) activity, was observed in all 
PCB126 exposed animals with similar median values in the two exposed groups, 550 and 
1000 ng/kg/day (p < 0.05). By comparing the number of 8-OHdG, 1, N6-εdA and N2, 3-
εG between the two PCB126 exposed groups respectively, it was found that none of them 
showed statistically significant between-group differences, which can not completely 
explain the difference of the tumor incidence in these two groups. Although significant 
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induction of EROD was observed in PCB153 exposed animals, the extent of induction by 
PCB 153 was less than two fold over vehicle controls, which implies the possiblity that 
oxidative DNA damage could be regulated by other pathways. 
 
         Different from oxidative DNA damage induced in PCB153 or PCB126 exposed 
animals, 8-OHdG, 1, N6-εdA and N2, 3-εG were all significantly induced in liver DNA of 
female rats after 53-weeks of exposure of the binary mixture of PCB153 (1000 µg/kg/day) 
and PCB126 (100 ng/kg/day), as shown in figure 5.3. Almost 2-fold higher 8-OHdG was 
found in the binary mixture exposed animals than in PCB153 or PCB126 alone, with a 
smaller increase in 1, N6-εdA and N2, 3-εG. Comparing the oxidative DNA damage data 
with the histopathology results of the 2-year cancer bioassay from NTP, it was found that 
higher cholangiocarcinoma incidence (75.5%) and hepatocellualr adenoma (67.7%) was 
accompanied with higher oxidative DNA damage in the binary mixture exposed animals 
compared with the animals exposed to PCB153 or 126 alone. Neither oxidative DNA 
damage, nor tumor incidence can simply be estimated by the TEF approach. Furthermore, 
more induction of CYP1A1 (3,219.5 ± 271.93 (pmol/minute per mg microsomal protein) 
was observed in the binary mixture exposed animals than the in the PCB126 treated 
animals, which may explain the higher oxidative DNA damage in these samples.   
 
         Although oxidative stress and oxidative DNA damage are regarded as one of the 
important mechanisms for hepatic toxicity of TCDD in rats, this hypothesis was proposed 
mainly based on previous acute high dose studies. Since cancer is a multistage chronic 
disease, an explanation of the relationship of these studies to the carcinogenic mechanism 
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of TCDD is likely to require additional key events, such as increased cell proliferation 
due to toxicity. To date, there are only three chronic studies focusing on oxidative stress 
or DNA damage in TCDD treated animals. Among them, two studies applied TCDD as a 
promoter in two-stage carcinogenesis models. Significant increases of 8-OHdG was 
observed in the female rat liver DNA after 30-week promotion by TCDD and 
diethylnitrosamine (DEN) initiation (48, 53).  Without TCDD, no 8-OHdG was induced 
after DEN initiation. The increase of 8-OHdG in the liver of rats was also found to be 
gender and estrogen dependent (48). Recently, Hassoun et al. (19) measured several 
biomarkers of oxidative stress in the livers of female rats following 32-weeks of TCDD 
exposure, including increased superoxide anion, lipid peroxidation and DNA single-
strand breaks. The highest increase of the mean values of superoxide anion, lipid 
peroxidation and DNA single-strand breaks was observed in the highest dose group of 
TCDD (100 ng/kg/day). However, in our studies, no significant increase of 8-OHdG was 
found in 100 ng/kg/day TCDD-treated female rat liver DNA after 53 weeks exposure. 
The disparity between all above studies may be due to differences between a two-stage 
model and one-stage model, poor understanding of metabolic pathways, deficiencies of 
8-OHdG as a biomarker for ROS stress, different periods of exposure, or various 
combinations of these reasons. In contrast to 8-OHdG, significant increases of 1, N6-εdA 
were observed in TCDD-treated rat liver DNA. Even the low dose, 22ng/kg/day, induced 
significant increases of this adduct compared to the 46ng/kg/day group, as shown in 
figure 5.4. Similar to 8-OHdG, no significant increase of 1, N2-εdG, M1dG, AcrdG, 4-
HNEdG and CrdG was observed in TCDD-treated rat liver DNA with the dose of 100 
ng/kg/day after 53 weeks exposure, which further indicated that TCDD did not induce 
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extensive amounts of oxidative DNA damage at high doses. Thus oxidative DNA damage 
may not be a significant contributor to TCDDs hepatic toxicity at high doses in chronic 
female rat studies. 
  
         Compared with the oxidative DNA damage induced by TCDD, higher mean levels 
of oxidative DNA damage were found in the liver DNA of female rats treated by the 
ternary mixture of TCDD, PCB126 and PeCDF with the same TEQ dose 100ng/kg/day, 
as shown in figure 5.5. Therefore, it can be concluded that oxidative DNA damage by 
DLCs cannot be simply estimated by TEF approach. Besides, Vezina found a limited 
subset of genes activated by PeCDF and PCB126, but not TCDD in 13-week exposed 
female rat livers, which included CAT, cytochrome b5 (CYB5), and COX oxidative 
stress stress response genes (60). This result suggests that PeCDF and PCB126 exposures 
may be more capable of inducing oxidative stress than TCDD. Both PCB126 and PeCDF 
were regarded as DLCs, and their dominant toxic effect was considered to be mediated 
by AhR-dependent pathways. Compared with the up-regulation of CYP450, it was found 
that the mean value of CYP1A1 was almost two fold higher in the livers of rats treated 
with the ternary mixture than in rats exposed to TCDD at a  100ng/kg/day TEQ dose (8, 
61), as shown in figure 5.7. The mean value of CYP1A2 in the ternary treated liver was 
almost half that of the same TEQ dose of the TCDD treated group (8, 61). Park et al. (54) 
found that the induction of CYP1A1 by TCDD was associated with oxidative DNA 
damage in the hepatoma Hepa1c1c7 cell line. Slezak et al. reported that CYP1A2 did not 
play a critical role in the oxidative stress response following TCDD exposure in animals 
(55). However, the connection between oxidative DNA damage and specific CYP450 up-
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regulation in TCDD treated animals still needs further study. The 2-year hepatocellular 
adenoma incidence data supported the application of the TEF approach in the risk 
assessment of DLCs, since similar dose-response curves were obtained in the TCDD and 
the ternary mixture exposed female rats (60). However, different cholangiocarcinoma 
incidence was observed in these groups, as shown in figure 5.7. These inconsistencies 
further hhighlight the complex interactions of oxidative DNA damage and carcinogenesis 
for DLCs in the liver of female rats.  
 
         Although oxidative stress and chronic inflammation are thought to play 
multifaceted roles in carcinogenesis, the relative contribution of oxidative DNA damage 
compared to other possible factors for carcinogenesis is still difficult to evaluate. At 
present, many PHAHs have been shown to induce oxidative stress in multiple biological 
systems, supporting a role for oxidative DNA damage, and genomic instability in PHAHs 
carcinogenicity. In addition, possible indirect genotoxicity, cytotoxicity, stimulation of 
cell proliferation, inhibition of apoptosis and induction of enzymes are all suggested to be 
involved in the toxicity of these compounds (41-45). Recent advances in scientific 
understanding of cancer biology also support the view that environmental chemicals can 
act through multiple toxicity pathways, modes and/or mechanisms of action to induce 
cancer (63, 64). However evaluating the relative weight of each possible important 
contributor to cancer induction is far more complicated than identifying them. Just like 
the saying, “there are at least two sides to a story and the truth is usually somewhere in 
between.” The role of oxidative DNA damage in the hepatic toxicity effect of PHAHs in 
female rats may be a case in point.  
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Figure 5.1 The structures of typical PHAHs in this study 
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*, p<0.05, ns, no significant difference, ∆, marginally significant, 0.05<p<0.10, comparison between 
control and exposed groups 
 
Figure 5.2 N2, 3-εG, 1, N6-εdA and 8-OHdG in the liver of female Sprague-Dawley 
rats exposed to PCB153 alone or PCB126 alone for 53 weeks 
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Figure 5.3 N2, 3-εG, 1, N6-εdA and 8-OHdG in the liver of female Sprague-Dawley 
rats exposed to the binary mixture of PCB153 and PCB126 for 53 weeks 
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Figure 5.4 1, N6-εdA and 8-OHdG in the liver of female Sprague-Dawley rats exposed 
to TCDD or the ternary mixture of TCDD, PCB126 and PeCDF for 53 weeks 
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Figure 5.5  1, N2-εdG, M1dG, AcrdG, CrdG and 4-HNEdG in the liver of female 
Sprague-Dawley rats exposed to TCDD or the ternary mixture of TCDD, PCB126 and 
PeCDF for 53 weeks 
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Significantly different (p≤0.05) from the vehicle control group by Dunn’s or Shirley’s test, n=10 
 
Figure 5.6 Tumor incidence (2 years) and enzyme induction in the liver of female 
Sprague-Dawley rats exposed to PCB153 or PCB126 for 53 weeks 
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Figure 5.7  Tumor incidence (2 years) and enzyme induction in the liver of female 
Sprague-Dawley rats exposed to TCDD or the mixture of TCDD, PCB126 and 
PeCDF for 53 weeks 
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CHAPTER VI 
GENERAL DISCUSSION 
 
A. SUMMARY OF FINDINGS 
 
         Reactive oxygen species (ROS) are highly reactive molecules formed by the 
incomplete one-electron reduction of oxygen or electronic excitation of O2 and produced 
as normal products of cellular metabolism. Under oxidative stress, considerable amounts 
of ROS are produced in vivo, which contributes to oxidative damage in nucleic acids, 
proteins and lipids. Among them, oxidative DNA damage has received the most study 
and is regarded as a possible key event in the mode of action of certain chemical 
carcinogens, such as 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (4, 5). Prior to this 
study, the possible association of oxidative DNA damage with hepatocarcinogenesis has 
been suggested, including monitoring of multiple forms of oxidative DNA damage. 
• Each ROS-induced DNA adduct has different mutagenic potential, as well as 
distinct formation and repair pathways (1, 2).  
• The induction of 1, N6-εdA in vinyl chloride (VC) exposed rodents was observed, 
which may represent contributions of both endogenous sources (lipid peroxidation) 
and exogenous (chemical exposure to vinyl chloride) sources (3).  
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• Significant induction of 8-OHdG was observed in the liver of intact female 
Sprague-Dawley rats exposed to TCDD for 30 weeks after diethylnitrosamine 
(DEN) initiation (4, 5).  
• The induction of hepatic lipid peroxidation (LPO), DNA single strand breaks and 
some oxidative DNA damage were observed in the livers of animals treated with 
acute doses of polyhalogenated aromatic hydrocarbons (PHAHs) (6-11). 
 
          The aims of this study were to develop a battery of assays for the measurement of 
ROS-induced DNA damage and to determine whether the oxidative DNA damage was 
increased in rats after various chemical exposures, including VC, TCDD, polychlorinated 
biphenyls (PCB) and 2,3,4,7,8-pentachlorodibenzofuran (PeCDF). The findings from this 
study were: 
1. Short-term (1-week) high dose (1100 ppm) VC exposure didn’t significantly 
induce endogenous 1, N6-εdA of weanling or adult rat.  
2. Several ROS-induced DNA adducts (8-OHdG, 1, N6-εdA, AcrdG and CrdG) 
showed a sex- and estrogen-dependent increase in the two-stage 
hepatocarcinogenesis studies, which agreed with the induction of 8-OHdG 
reported previously (4, 5). Higher amounts of LPO-induced DNA adducts were 
observed in the liver of intact female rats without E2 supplement than 
ovariectomized (OVX) female rats with 17β-estradiol (E2) supplement after 
TCDD promotion and DEN initiation. 
3. The induction of ROS-induced DNA adducts was observed in animals chronically 
treated with both dioxin-like compounds (DLCs) and nondioxin-like compounds 
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(NDLCs), indicating that oxidative stress was formed by both AhR-dependent and 
independent pathways. Higher concentrations of LPO-induced DNA adducts were 
detected in the ternary mixture TCDD, PeCDF and PCB126 than pure TCDD 
exposed samples with the same toxic equivalency factor (TEF) values, indicating 
TEF methodology can not accurately estimate ROS-induced DNA adducts. Much 
lower increase of oxidative DNA adducts were detected in pure TCDD-treated 
animals (chapter 5) than the animals exposed to TCDD as a promotor after DEN 
intiation (chapter 4) (5). 
 
The detection of ROS-induced DNA adducts 
          Different LC-MS/MS systems were evaluated in this study, including conventional 
UPLC-MS/MS, capillary LC-MS/MS and nano UPLC-MS/MS. Using 1, N6-εdA, the 
sensitivity of nano UPLC-MS/MS was almost 4 times higher than the capillary system, 
and 20 times higher than the conventional UPLC-MS/MS. The robustness of this system 
was assessed by measuring 1, N6-εdA in the DNA of (13C2)-VC exposed Sprague-Dawley 
rats. Using nanoLC-MS/MS with sensitive nanospray interface, sub-fematomole limits of 
detection (LOD) were obtained for most of ROS-induced DNA adducts in this study. The 
LOD of 1, N6-εdA and 1, N2-εdG was several hundred atmole; the LOD of   AcrdG, CrdG 
and 4-HNEdG was 50 atmole on column. Enzymatic digestion and sample purification by 
LC were the other two steps optimized for the detection of ROS-induced DNA adducts. 
System B (NP1+AP+PDE) (12) was selected as the final digestion method for these 
ROS-induced DNA adducts. Because 4-HNEdG and CrdG were bulky DNA adducts, 
DNase I was added into the system to ensure the complete digestion. TEMPO (5µl, 
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1.5mM) was added to inhibit artifact formation for 8-OHdG detection. A short LC 
purification method was developed for 8-OHdG and 1, N6-εdA respectively in order to 
remove possible interference and artifact. Complete separation of AcrdG and dA was 
realized when 0.1% formic acid was added into 5mM ammonium formate in water as 
mobile phase A. CrdG and 4-HNEdG were processed together using high composition of 
organic solvent in mobile pahse. M1dG was detected directly by nanoUPLC-MS/MS after 
LC purification.. 
 
The endogenous and exogenous 1, N6-εdA in weanling and adult Sprague-Dawley 
rats exposed to VC by inhalation 
 
          Both adult and weanling Sprague-Dawley rats were exposed to 1100 ppm (13C2)-
VC for 1 week (6 h/day, 5 days/week). Weanling animals were sacrificed immediately. 
Adult animals were sacrificed immediately, 2 weeks, 4 weeks, and 8 weeks post exposure. 
Using the sensitive nanoUPLC-MS/MS assay developed in this study, both endogenous 
NA- and exogenous (13C2)-1, N6-εdA was measured in the liver, lung and kidney of these 
animals. The distribution pattern of (13C2)-1, N6-εdA in both adult and weanling animals 
clearly indicated that liver was the primary metabolic organ of VC in rodents (p<0.05), 
followed by lung and kidney respectively. The NA-1, N6-εdA level did not show a 
significant difference in the liver of adult and weanling rats after VC exposure. (13C2)-1, 
N6-εdA was detected only in the liver, lung and kidney in the exposed adult animals 
without recovery, but was not detected in post exposure animals. This implied that 1, N6-
εdA was repaired rapidly in adult rats after VC exposure. Short-term high dose VC 
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exposure (1 week, 1100ppm) did not induce significant ROS related 1, N6-εdA in the 
liver of these animals, which implied that 1, N6-εdA from endogenous sources did not 
contribute to the genotoxicity of VC in the liver of Sprague-Dawley rats after short-term 
high dose exposure.  
 
ROS-induced DNA adducts in the liver of Sprague-Dawley rats after DEN initiation 
and TCDD promotion 
 
          In this study, several major oxidative DNA adducts were detected in the liver DNA 
from the same animal study reported by Wyde (5), including 8-OHdG, 1, N6-εdA, 1, N2-
propano-2’-deoxyguanosines generated from acrolein (AcrdG), chrotonaldehyde (CrdG). 
Significant induction of 8-OHdG and 1, N6-εdA was found in the liver of TCDD-treated 
both intact female rats and E2 supplemented OVX female rats. The mean values of these 
DNA adducts in the intact TCDD exposed and control female hepatic DNA were 19.5 ± 
10.7/106 dG and 6.4 ± 2.2/106 dG for 8-OHdG, 20.3 ± 8.9/108 dA and 5.8 ± 2.4/108 dA 
for 1, N6-εdA, 21.4 ± 6.2/107 dG and 6.8 ± 2.0/107 dG for AcrdG, and 6.2 ± 1.4/109 dG 
and 3.2 ± 1.9/109 dG for CrdG respectively. Following 30 weeks TCDD promotion, 
higher levels of 1, N6-εdA, AcrdG and CrdG were detected in intact female rats than E2 
supplemented OVX female rats (1, N6-εdA, 9.1 ± 2.2/108 dA; AcrdG, 9.1 ± 4.0/107 dG; 
CrdG, 4.3 ± 0.8/109 dG). 1.7 mg E2 supplement induced higher 8-OHdG than 0.18 mg E2 
supplement in the liver of OVX TCDD-treated female rats, with the mean levels of 22.3 
± 13.4/106 dG for 1.7 mg E2 and 12.1 ± 11.8/106 dG for 0.18 mg E2 supplemented group 
respectively. Without E2, none of these DNA adducts were significantly induced in the 
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liver of OVX female rats treated by TCDD. No significant increase of 1, N6-εdA or 8-
OHdG was observed in male rats with or without E2 supplement following 30 weeks 
TCDD promotion. These results further confirmed that the induction of ROS relevant 
DNA adducts occurs via a sex-specific and estrogen-dependent mechanism. A more 
complicated interaction among TCDD, estrogen and oxidative DNA damage was implied 
in this study, considering that higher amounts of DNA adducts induced by LPO were 
found in intact female rats, than E2 supplemented OVX rats after TCDD promotion. 
 
ROS-induced DNA adducts in the liver of Sprague-Dawley rats after chronic 
exposure of PHAHs and their mixtures 
 
         ROS-induced DNA adducts were measured in liver DNA of female Sprague-
Dawley rats following 53-week exposures to PHAHs, which included PCB153 
(nondioxin-like compound), PCB126 (dioxin-like compound), TCDD, the binary mixture 
of PCB153 and PCB126, and the ternary mixture of TCDD, PCB126 and PeCDF. Eight 
DNA adducts were measured to provide the comprehensive profile of oxidative DNA 
lesions, including 8-OHdG, 1, N6-εdA, N2, 3-εG, 1, N2-εdG, M1dG, AcrdG, CrdG, and 4-
HNEdG. Following 53-week exposures, significant increases of 1, N6-εdA (1.09 ± 
0.33/108 vs 0.48 ± 0.09/108 unmodified nucleosides, p = 0.029) and marginally 
significant increase of N2, 3-εG (0.69 ± 0.08/108 vs 0.45 ± 0.15/108 unmodified 
nucleosides, p = 0.07) were observed in the highest dose of PCB126 treated animals 
compared with the control group. 8-OHdG was slightly increased (1.70 ± 0.76/106 vs 
1.10 ± 0.38/106 unmodified nucleosides, p = 0.083). Although statistically significant 
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increase of 8-OHdG, N2, 3-εG and 1, N6-εdA were not observed in PCB153 exposed 
animals, all these adducts were slightly enhanced, suggesting that both AhR-dependent 
and independent pathways may induce oxidative DNA damage. Following 53-week 
exposures to the binary mixture of PCB153 (1000µg/kg/day) and PCB126 
(100ng/kg/day), higher amounts of 8-OHdG were detected in the binary group than in 
groups exposed to PCB126 or 153 alone, although both N2, 3-εG (0.70 ± 0.21/108 
unmodified nucleosides) and 1, N6-εdA (1.01 ± 0.22/108 unmodified nucleosides) had 
numbers of adducts similar to the PCB126 (100ng/kg/day) exposed group. Oxidative 
DNA lesions provided consistent support for the conclusion that TEF methodology 
cannot fully account for ROS-derived DNA adducts in the binary mixture studies, which 
agrees with tumor incidence (2-year exposure), toxicity and CYP1A1 induction data (53-
week exposure) in the same animals. Following 53-week exposures, a significant increase 
of 1, N6-εdA was observed in all animals exposed to TCDD or the ternary mixture of 
TCDD, PeCDF and TCDD, including TEQ dose 22, 46 and 100 ng/kg/day groups. 8-
OHdG was not significantly induced in most TCDD and ternary mixture treated groups 
except the 100 ng/kg/day ternary mixture treated group. Significant increases of 1, N2-
εdG, CrdG, AcrdG and M1dG were detected in the ternary mixture treated animals 
(100ng/kg/day) but not the TCDD treated group (100ng/kg/day) relative to the respective 
control groups.  Although no significant increase of 4-HNEdG was found in the ternary 
mixture treated animals (3.49 ± 0.96/109 unmodified nucleosides), the mean levels of 4-
HNEdG were still higher than the TCDD treated group (2.52 ± 0.51/109 unmodified 
nucleosides). Although similar tumor incidence was observed in TCDD and the ternary 
mixture treated animals with the same TEQ dose, indicating that TEF methodology could 
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be applied to the prediction of hepatic tumor incidence of the ternary mixture (13), this 
approach cannot be simply applied to estimate the oxidative DNA lesions induced by this 
mixture in the liver of these animals.  
         
B. FUTURE DIRECTIONS 
 
Evaluate the sensitivity of different ROS-induced DNA adducts as biomarker of 
oxidative stress 
 
      At present, we monitored seven different ROS-induced DNA adducts, 8-OHdG, 
formed directly from ROS, and six LPO-induced DNA adducts including 1, N6-εdA, 1, 
N2-εdG, M1dG, AcrdG, CrdG and 4-HNEdG. However, under conditions of oxidative 
stress, multiple DNA lesions can be produced by the direct reaction of ROS with DNA, 
as shown in figure 6.1. The formation of 8-OHdG and 8-OHdA competes with the 
opening of imidazole ring in purine, which is reduced to yield 2, 6-Diamino-4-hydroxy-5-
formamidopyrimidine (FapyGua) and 4, 6-Diamino-5-formamidopyrimidine (FapyAde) 
(14). 2΄-deoxycytidine can deaminate and/or dehydrate when reacting with ROS, 
inducing the formation of 5-hydroxy-2΄-deoxycytidine (5-OHdC) and 5-hydroxyuracil (5-
OHUra) as the major products (15). ROS can attack several sites on thymine and induce 
the formation of thymine glycol, 5-(hydroxymethyl)uracil and 5-formyluracil (15). 
However, due to the difficulty of sample purification by reverse-phase LC for most DNA 
adducts directly induced by the reaction of ROS and DNA, only 8-OHdG was selected as 
a monitoring biomarker in this study. Therefore, it is necessary to monitor other adducts, 
such as FapyGua, 8-OHdA, FapyAde, 5-OHdC, 5-OHUra and Thymine glycol. Because 
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most of these adducts have short retention time on reverse phase (RP) columns, it is 
difficult to separate them from unmodified nucleosides or bases. Fortunately, the 
development of hydrophilic interaction liquid chromatography (HILIC) columns gave us 
a second choice. As a version of normal phase liquid chromatography, HILIC columns 
are more suitable for the separation of polar compounds, which means that compounds 
with short retention times on RP columns tend to have long retention times on HILIC 
columns (17).  
 
      One of the important aims of adductomics (18) is to find the most sensitive 
biomarkers for risk assessment of chemical carcinogenesis. In our study, multiple DNA 
adducts were measured in both OVX and TEF studies. 1, N6-εdA showed the best 
sensitivities among all of the studied adducts. However, comprehensive studies are still 
necessary in order to identify the most sensitive biomarker for identifying ROS as an 
important Mode of Action for toxicology, chemical carcinogenesis and risk assessment.  
Examine effect of length of exposure on ROS-induced DNA adducts 
 
      In this study, we found significant induction of ROS-induced DNA adducts in the 
liver of female Sprague-Dawley rats after exposure to PHAHs for 53 weeks. Previously, 
Wyde et al. studied the induction of 8-OHdG in the liver of female rats after TCDD 
promotion for 20 and 30 weeks after DEN initiation (5), and found that higher 8-OHdG 
was observed in the 30-week treated animal than the 20-week treated group. Besides, he 
also found that sing high dose (1000 and 3000 ng/kg) of TCDD without DEN intiation 
did not induce 8-OHdG in the liver of female rats. Jeong examined the induction of 
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M1dG in the liver of female C57BL/6J mice treated by a single dose of diverse PHAH 
mixtures and found that no increases of M1dG in these animals although significant 
increase of this adduct was observed in the liver of female Sprague-Dawley rats after 
exposure to PHAH for 53 weeks (20). Although these two studies consistently implied 
that the induction of ROS-induced DNA adducts was a chronic effect of PHAH in the 
liver of rodents, comprehensive systematic studies are still limited for the effect of 
exposure length on ROS-induced DNA adducts in female rats after PHAH exposure. 
Fortunately, NTP also examined the hepatoxicity of female rats exposed to PHAHs for 13 
weeks and 31 weeks. Using these unique precious samples, we can evaluate the effect of 
length of exposure on ROS-induced DNA adducts in the liver of these animals. 
Measure estrogen-induced DNA adducts, abasic sites and ROS-induced DNA 
adducts in the livers of female Sprague-Dawley rats exposed to TCDD. 
 
       In our studies, ROS-induced DNA adducts showed an estrogen-dependent pattern in 
the liver of female OVX Sprague-Dawley rats exposed to TCDD for 30 weeks after DEN 
initiation. But the association of quinone-redox cycling from estrogen and oxidative DNA 
damage is still unknown. The contribution of estrogen to the indirect genotoxicity of 
TCDD is a mystery. Therefore, monitoring both estrogen-induced bulky DNA adducts 
(19), the chemical-specific biomarkers of exposure, and ROS-induced DNA adducts in 
these animals can help us better understand the role of estrogen in the hepatoxicity of 
TCDD in this two-stage model. The dominant biological effects of estrogen-induced 
DNA adducts is to induce abasic sites (AP sites). N3 adenine adducts of estrogen are lost 
from DNA rapidly; the half-lives of N7 guanine adducts of estrogen are only 3 hours in 
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water (21). Therefore, in order to further confirm the important effect of estrogen on the 
hepatoxicity of TCDD, we can measure estrogen-induced DNA adducts, AP sites and 
ROS-induced DNA adducts in the liver of female OVX and intact rats and explore their 
difference. 
 
      Estrogen-induced DNA adducts, AP sites and ROS-induced DNA adducts can also be 
measured in the liver of female Sprague-Dawley rats after 30-week or 52-week exposure 
of pure TCDD. The results of the one-stage carcinogenesis samples can be compared 
with the two-stage carcinogenesis samples to determine whether there is difference 
between them. 
 
      All above results will help us better understand the role of estrogen in the induction of 
ROS-induced DNA adducts in the liver of female rats after TCDD exposure. 
Compare the dose/time-response of ROS-induced DNA adducts with oxidative 
stress-related gene expression in the livers of female Sprague-Dawley rats exposed to 
PHAHs. 
 
       The rapid development of genomics provides us novel techniques to examine the 
gene expression profile in toxicology studies. Using DNA microarray analysis, Olson et 
al. identified a subgroup of genes activated by PeCDF and PCB126, but not TCDD in the 
liver of female Sprague-Dawley rats exposed to PHAHs for 13 weeks. They included 
CAT, cytochrome b5 (CYB5), and COX oxidatative stress response genes (22). This result 
may indicate that the induction of oxidative stress in the liver of these animals is 
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mediated through a unique, AhR-independent pathway activated by PeCDF and PCB126.  
Using LC-MS/MS, we found significant induction of the oxidative DNA damage in the 
liver of female rats after exposure to PHAHs for 53 weeks. Therefore, a dose/time-
response comparison between these two distinct biomarkers (ROS-induced DNA adducts 
vs ROS-relevant gene expression) will help us better evaluate their sensitivity for 
evaluating oxidative stress. 
Measure ROS-induced DNA adducts in the other target organs of female rats 
exposed to PHAHs 
 
      Significant induction of ROS-induced DNA adducts were found in the liver of female 
Sprague-Dawley rats chronically exposed to PHAHs in our studies, which indicates that 
oxidative DNA damage does contribute to the hepatoxicity of PHAHs. However, whether 
the accumulation of ROS-induced DNA damage contributes to the toxicity of other 
organs in these animals after PHAHs exposure is still unknown. Since lung and kidney 
are also the target organs of PHAHs and chronic inflammation is associated with diverse 
chronic diseases, it is worthwhile to measure ROS-induced DNA adducts in these organ 
and compare the results with those in the liver to further determine whether ROS-induced 
DNA adducts are good biomarkers to indicate different toxicity across different tissues. 
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Figure 6.1 Major promutagenic DNA adducts induced by ROS 
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